<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Atherosclerosis - Wikipedia, the free encyclopedia</title>
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />
<meta name="generator" content="MediaWiki 1.23wmf19" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Atherosclerosis" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Atherosclerosis&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Atherosclerosis&amp;action=edit" />
<link rel="apple-touch-icon" href="//bits.wikimedia.org/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="//bits.wikimedia.org/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="http://en.wikipedia.org/wiki/Atherosclerosis" />
<link rel="stylesheet" href="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.ui.button%7Cskins.common.interface%7Cskins.vector.styles&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: enwiki:resourceloader:filter:minify-css:7:3904d24a08aa08f6a68dc338f9be277e */</style>

<script src="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Atherosclerosis","wgTitle":"Atherosclerosis","wgCurRevisionId":601810521,"wgRevisionId":601810521,"wgArticleId":85385,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Pages containing cite templates with deprecated parameters","Pages with citations lacking titles","Pages with citations having bare URLs","CS1 errors: dates","All articles with unsourced statements","Articles with unsourced statements from March 2013","Articles needing additional references from October 2013","All articles needing additional references","Articles with unsourced statements from August 2010","Wikipedia articles needing clarification from December 2010","Articles using fixed number of columns in reflist","Commons category with local link same as on Wikidata","Articles with Open Directory Project links","Diseases of arteries, arterioles and capillaries","Vascular diseases","Medical conditions related to obesity","Inflammations"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Atherosclerosis","wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"templateEditor":false,"templates":false,"preview":false,"previewDialog":false,"publish":false,"toc":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"isPageWatched":false,"magnifyClipIconURL":"//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png","pageLanguageCode":"en","pageLanguageDir":"ltr","svgMaxSize":2048},"wikilove-recipient":"","wikilove-anon":0,"wgGuidedTourHelpGuiderUrl":"Help:Guided tours/guider","wgFlowTermsOfUseEdit":"By saving changes, you agree to our \u003Ca class=\"external text\" href=\"//wikimediafoundation.org/wiki/Terms_of_use\"\u003ETerms of Use\u003C/a\u003E and agree to irrevocably release your text under the \u003Ca rel=\"nofollow\" class=\"external text\" href=\"//creativecommons.org/licenses/by-sa/3.0\"\u003ECC BY-SA 3.0 License\u003C/a\u003E and \u003Ca class=\"external text\" href=\"//en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License\"\u003EGFDL\u003C/a\u003E","wgULSAcceptLanguageList":["ko-kr"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q13380381"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function(){mw.user.options.set({"ccmeonemails":0,"cols":80,"date":"default","diffonly":0,"disablemail":0,"editfont":"default","editondblclick":0,"editsectiononrightclick":0,"enotifminoredits":0,"enotifrevealaddr":0,"enotifusertalkpages":1,"enotifwatchlistpages":0,"extendwatchlist":0,"fancysig":0,"forceeditsummary":0,"gender":"unknown","hideminor":0,"hidepatrolled":0,"imagesize":2,"math":0,"minordefault":0,"newpageshidepatrolled":0,"nickname":"","norollbackdiff":0,"numberheadings":0,"previewonfirst":0,"previewontop":1,"rcdays":7,"rclimit":50,"rememberpassword":0,"rows":25,"showhiddencats":false,"shownumberswatching":1,"showtoolbar":1,"skin":"vector","stubthreshold":0,"thumbsize":4,"underline":2,"uselivepreview":0,"usenewrc":0,"watchcreations":1,"watchdefault":0,"watchdeletion":0,"watchlistdays":3,"watchlisthideanons":0,"watchlisthidebots":0,"watchlisthideliu":0,"watchlisthideminor":0,"watchlisthideown":0,"watchlisthidepatrolled":0,"watchmoves":0,
"wllimit":250,"useeditwarning":1,"prefershttps":1,"flaggedrevssimpleui":1,"flaggedrevsstable":0,"flaggedrevseditdiffs":true,"flaggedrevsviewdiffs":false,"usebetatoolbar":1,"usebetatoolbar-cgd":1,"visualeditor-enable":0,"visualeditor-enable-experimental":0,"visualeditor-betatempdisable":0,"wikilove-enabled":1,"echo-subscriptions-web-page-review":true,"echo-subscriptions-email-page-review":false,"ep_showtoplink":false,"ep_bulkdelorgs":false,"ep_bulkdelcourses":true,"ep_showdyk":true,"echo-subscriptions-web-education-program":true,"echo-subscriptions-email-education-program":false,"echo-notify-show-link":true,"echo-show-alert":true,"echo-email-frequency":0,"echo-email-format":"html","echo-subscriptions-email-system":true,"echo-subscriptions-web-system":true,"echo-subscriptions-email-other":false,"echo-subscriptions-web-other":true,"echo-subscriptions-email-edit-user-talk":false,"echo-subscriptions-web-edit-user-talk":true,"echo-subscriptions-email-reverted":false,
"echo-subscriptions-web-reverted":true,"echo-subscriptions-email-article-linked":false,"echo-subscriptions-web-article-linked":false,"echo-subscriptions-email-mention":false,"echo-subscriptions-web-mention":true,"echo-subscriptions-web-edit-thank":true,"echo-subscriptions-email-edit-thank":false,"echo-subscriptions-web-flow-discussion":true,"echo-subscriptions-email-flow-discussion":false,"gettingstarted-task-toolbar-show-intro":true,"uls-preferences":"","language":"en","variant-gan":"gan","variant-iu":"iu","variant-kk":"kk","variant-ku":"ku","variant-shi":"shi","variant-sr":"sr","variant-tg":"tg","variant-uz":"uz","variant-zh":"zh","searchNs0":true,"searchNs1":false,"searchNs2":false,"searchNs3":false,"searchNs4":false,"searchNs5":false,"searchNs6":false,"searchNs7":false,"searchNs8":false,"searchNs9":false,"searchNs10":false,"searchNs11":false,"searchNs12":false,"searchNs13":false,"searchNs14":false,"searchNs15":false,"searchNs100":false,"searchNs101":false,"searchNs108":false,
"searchNs109":false,"searchNs118":false,"searchNs119":false,"searchNs446":false,"searchNs447":false,"searchNs710":false,"searchNs711":false,"searchNs828":false,"searchNs829":false,"gadget-teahouse":1,"gadget-ReferenceTooltips":1,"gadget-DRN-wizard":1,"gadget-charinsert":1,"gadget-mySandbox":1,"variant":"en"});},{},{});mw.loader.implement("user.tokens",function(){mw.user.tokens.set({"editToken":"+\\","patrolToken":false,"watchToken":false});},{},{});
/* cache key: enwiki:resourceloader:filter:minify-js:7:868e43d07ede2616d2d1dc3507cd8145 */
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","skins.vector.compactPersonalBar.defaultTracking","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","wikibase.client.init","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" /><!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static-1.23wmf19/skins/vector/csshover.min.htc")}</style><![endif]--></head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Atherosclerosis skin-vector action-view vector-animateLayout">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>
			<div id="mw-js-message" style="display:none;"></div>
						<div id="siteNotice"><!-- CentralNotice --></div>
						<h1 id="firstHeading" class="firstHeading" lang="en"><span dir="auto">Atherosclerosis</span></h1>
						<div id="bodyContent">
								<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-navigation">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="dablink">For the journal, see <a href="/wiki/Atherosclerosis_(journal)" title="Atherosclerosis (journal)">Atherosclerosis (journal)</a>.</div>
<table class="infobox" cellspacing="3" style="border-spacing:3px;width:22em;">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey;">Atherosclerosis</th>
</tr>
<tr>
<td colspan="2" style="text-align:center;"><i>Classification and external resources</i></td>
</tr>
<tr>
<td colspan="2" style="text-align:center;"><a href="/wiki/File:Endo_dysfunction_Athero.PNG" class="image"><img alt="Endo dysfunction Athero.PNG" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9a/Endo_dysfunction_Athero.PNG/230px-Endo_dysfunction_Athero.PNG" width="230" height="253" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/9a/Endo_dysfunction_Athero.PNG/345px-Endo_dysfunction_Athero.PNG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9a/Endo_dysfunction_Athero.PNG/460px-Endo_dysfunction_Athero.PNG 2x" /></a><br />
<div>The progression of atherosclerosis (size exaggerated; see text)</div>
</td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a href="/wiki/ICD-10_Chapter_I" title="ICD-10 Chapter I" class="mw-redirect">I</a><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2010/en#/I70">70</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=440">440</a>, <a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=414.0">414.0</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb1039.htm">1039</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000171.htm">000171</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/med/topic182.htm">med/182</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&amp;term=D050197">D050197</a></td>
</tr>
</table>
<p><b>Atherosclerosis</b> (also known as <b>arteriosclerotic vascular disease</b> or <b>ASVD</b>) is a specific form of <a href="/wiki/Arteriosclerosis" title="Arteriosclerosis">arteriosclerosis</a> in which an artery wall thickens as a result of the accumulation of calcium and fatty materials such as <a href="/wiki/Cholesterol" title="Cholesterol">cholesterol</a> and <a href="/wiki/Triglyceride" title="Triglyceride">triglyceride</a>. It reduces the elasticity of the artery walls and therefore allows less blood to travel through. This also increases blood pressure. It is a <a href="/wiki/Syndrome" title="Syndrome">syndrome</a> affecting <a href="/wiki/Artery" title="Artery">arterial</a> <a href="/wiki/Blood_vessel" title="Blood vessel">blood vessels</a>, a chronic inflammatory response in the walls of arteries, caused largely by the accumulation of <a href="/wiki/Macrophage" title="Macrophage">macrophages</a> and <a href="/wiki/White_blood_cells" title="White blood cells" class="mw-redirect">white blood cells</a> and promoted by <a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">low-density lipoproteins</a> (LDL, plasma proteins that carry cholesterol and <a href="/wiki/Triglycerides" title="Triglycerides" class="mw-redirect">triglycerides</a>) without adequate removal of fats and cholesterol from the macrophages by functional <a href="/wiki/High-density_lipoprotein" title="High-density lipoprotein">high-density lipoproteins</a> (HDL) (see <a href="/wiki/ApoA-1_Milano" title="ApoA-1 Milano">apoA-1 Milano</a>). It is commonly referred to as a hardening or furring of the arteries. It is caused by the formation of multiple <a href="/wiki/Atheroma" title="Atheroma">plaques</a> within the arteries.<sup id="cite_ref-1" class="reference"><a href="#cite_note-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-:0_2-0" class="reference"><a href="#cite_note-:0-2"><span>[</span>2<span>]</span></a></sup> The <a href="/wiki/Atheroma" title="Atheroma">atheromatous plaque</a> is divided into three distinct components:</p>
<ol>
<li>The <a href="/wiki/Atheroma" title="Atheroma">atheroma</a> ("lump of gruel", from <a href="/wiki/Greek_language" title="Greek language">Greek</a> ἀθήρα <i>(athera)</i>, meaning "<a href="/wiki/Gruel" title="Gruel">gruel</a>"), which is the nodular accumulation of a soft, flaky, yellowish material at the center of large plaques, composed of <a href="/wiki/Macrophage" title="Macrophage">macrophages</a> nearest the <a href="/wiki/Lumen_(anatomy)" title="Lumen (anatomy)">lumen</a> of the artery.</li>
<li>Underlying areas of <a href="/wiki/Cholesterol" title="Cholesterol">cholesterol</a> crystals.</li>
<li>Calcification at the outer base of older/more advanced <a href="/wiki/Lesions" title="Lesions" class="mw-redirect">lesions</a>.</li>
</ol>
<p>The following terms are similar, yet distinct, in both spelling and meaning, and can be easily confused: <a href="/wiki/Arteriosclerosis" title="Arteriosclerosis">arteriosclerosis</a>, <a href="/wiki/Arteriolosclerosis" title="Arteriolosclerosis">arteriolosclerosis</a>, and atherosclerosis. <i>Arteriosclerosis</i> is a general term describing any hardening (and loss of elasticity) of medium or large arteries (from <a href="/wiki/Greek_language" title="Greek language">Greek</a> ἀρτηρία <i>(artēria)</i>, meaning "<a href="/wiki/Artery" title="Artery">artery</a>", and σκλήρωσις <i>(<a href="//en.wiktionary.org/wiki/sclerosis" class="extiw" title="wikt:sclerosis">sklerosis</a>)</i>, meaning "hardening"); <i>arteriolosclerosis</i> is any hardening (and loss of elasticity) of <a href="/wiki/Arteriole" title="Arteriole">arterioles</a> (small arteries); <i>atherosclerosis</i> is a hardening of an artery specifically due to an atheromatous plaque. The term <i>atherogenic</i> is used for substances or processes that cause atherosclerosis.<sup class="Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (March 2013)">citation needed</span></a></i>]</sup></p>
<p>Atherosclerosis is a chronic disease that remains <a href="/wiki/Asymptomatic" title="Asymptomatic">asymptomatic</a> for decades.<sup id="cite_ref-:1_3-0" class="reference"><a href="#cite_note-:1-3"><span>[</span>3<span>]</span></a></sup> Atherosclerotic lesions, or atherosclerotic plaques are separated into two broad categories: Stable and unstable (also called vulnerable).<sup id="cite_ref-4" class="reference"><a href="#cite_note-4"><span>[</span>4<span>]</span></a></sup> The pathobiology of atherosclerotic lesions is very complicated but generally, stable atherosclerotic plaques, which tend to be asymptomatic, are rich in <a href="/wiki/Extracellular_matrix" title="Extracellular matrix">extracellular matrix</a> and <a href="/wiki/Smooth_muscle_cells" title="Smooth muscle cells" class="mw-redirect">smooth muscle cells</a>, while, unstable plaques are rich in <a href="/wiki/Macrophages" title="Macrophages" class="mw-redirect">macrophages</a> and <a href="/wiki/Foam_cells" title="Foam cells" class="mw-redirect">foam cells</a> and the extracellular matrix separating the lesion from the arterial lumen (also known as the <a href="/wiki/Fibrous_cap" title="Fibrous cap">fibrous cap</a>) is usually weak and prone to rupture.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5"><span>[</span>5<span>]</span></a></sup> Ruptures of the fibrous cap expose thrombogenic material, such as <a href="/wiki/Collagen" title="Collagen">collagen</a><sup id="cite_ref-6" class="reference"><a href="#cite_note-6"><span>[</span>6<span>]</span></a></sup> to the circulation and eventually induce <a href="/wiki/Thrombus" title="Thrombus">thrombus</a> formation in the lumen. Upon formation, intraluminal thrombi can occlude arteries outright (e.g. coronary occlusion), but more often they detach, move into the circulation and eventually occluding smaller downstream branches causing <a href="/wiki/Thromboembolism" title="Thromboembolism" class="mw-redirect">thromboembolism</a>. Apart from <a href="/wiki/Thromboembolism" title="Thromboembolism" class="mw-redirect">thromboembolism</a>, chronically expanding atherosclerotic lesions can cause complete closure of the lumen. Interestingly, chronically expanding lesions are often asymptomatic until lumen <a href="/wiki/Stenosis" title="Stenosis">stenosis</a> is so severe (usually over 80%) that blood supply to downstream tissue(s) is insufficient, resulting in <a href="/wiki/Ischemia" title="Ischemia">ischemia</a>.</p>
<p>These complications of advanced atherosclerosis are chronic, slowly progressive and cumulative. Most commonly, soft plaque suddenly ruptures (see <a href="/wiki/Vulnerable_plaque" title="Vulnerable plaque">vulnerable plaque</a>), causing the formation of a <a href="/wiki/Thrombus" title="Thrombus">thrombus</a> that will rapidly slow or stop blood flow, leading to death of the tissues fed by the artery in approximately 5 minutes. This catastrophic event is called an <a href="/wiki/Infarction" title="Infarction">infarction</a>. One of the most common recognized scenarios is called <a href="/wiki/Coronary_thrombosis" title="Coronary thrombosis">coronary thrombosis</a> of a <a href="/wiki/Coronary_artery" title="Coronary artery" class="mw-redirect">coronary artery</a>, causing <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a> (a heart attack). The same process in an artery to the brain is commonly called <a href="/wiki/Stroke" title="Stroke">stroke</a>. Another common scenario in very advanced disease is <a href="/wiki/Claudication" title="Claudication">claudication</a> from insufficient blood supply to the legs. Atherosclerosis affects the entire artery tree, but mostly larger, high-pressure vessels such as the coronary, renal, femoral, cerebral, and carotid arteries. These are termed "<a href="/wiki/Clinically_silent" title="Clinically silent" class="mw-redirect">clinically silent</a>" because the person having the infarction does not notice the problem and does not seek medical help, or when they do, physicians do not recognize what has happened.</p>
<div class="toclimit-3">
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Causes"><span class="tocnumber">2</span> <span class="toctext">Causes</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#Risk_factors"><span class="tocnumber">2.1</span> <span class="toctext">Risk factors</span></a>
<ul>
<li class="toclevel-3 tocsection-4"><a href="#Modifiable"><span class="tocnumber">2.1.1</span> <span class="toctext">Modifiable</span></a></li>
<li class="toclevel-3 tocsection-5"><a href="#Nonmodifiable"><span class="tocnumber">2.1.2</span> <span class="toctext">Nonmodifiable</span></a></li>
<li class="toclevel-3 tocsection-6"><a href="#Lesser_or_uncertain"><span class="tocnumber">2.1.3</span> <span class="toctext">Lesser or uncertain</span></a></li>
<li class="toclevel-3 tocsection-7"><a href="#Dietary"><span class="tocnumber">2.1.4</span> <span class="toctext">Dietary</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1 tocsection-8"><a href="#Pathophysiology"><span class="tocnumber">3</span> <span class="toctext">Pathophysiology</span></a>
<ul>
<li class="toclevel-2 tocsection-9"><a href="#Cellular"><span class="tocnumber">3.1</span> <span class="toctext">Cellular</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Calcification_and_lipids"><span class="tocnumber">3.2</span> <span class="toctext">Calcification and lipids</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Visible_features"><span class="tocnumber">3.3</span> <span class="toctext">Visible features</span></a></li>
<li class="toclevel-2 tocsection-12"><a href="#Rupture_and_stenosis"><span class="tocnumber">3.4</span> <span class="toctext">Rupture and stenosis</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-13"><a href="#Diagnosis"><span class="tocnumber">4</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#Prevention"><span class="tocnumber">5</span> <span class="toctext">Prevention</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#Treatment"><span class="tocnumber">6</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2 tocsection-16"><a href="#Statins"><span class="tocnumber">6.1</span> <span class="toctext">Statins</span></a></li>
<li class="toclevel-2 tocsection-17"><a href="#Diet"><span class="tocnumber">6.2</span> <span class="toctext">Diet</span></a></li>
<li class="toclevel-2 tocsection-18"><a href="#Surgery"><span class="tocnumber">6.3</span> <span class="toctext">Surgery</span></a></li>
<li class="toclevel-2 tocsection-19"><a href="#Other"><span class="tocnumber">6.4</span> <span class="toctext">Other</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-20"><a href="#Prognosis"><span class="tocnumber">7</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1 tocsection-21"><a href="#Research"><span class="tocnumber">8</span> <span class="toctext">Research</span></a>
<ul>
<li class="toclevel-2 tocsection-22"><a href="#miRNA"><span class="tocnumber">8.1</span> <span class="toctext">miRNA</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-23"><a href="#Economics"><span class="tocnumber">9</span> <span class="toctext">Economics</span></a></li>
<li class="toclevel-1 tocsection-24"><a href="#See_also"><span class="tocnumber">10</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-25"><a href="#Footnotes"><span class="tocnumber">11</span> <span class="toctext">Footnotes</span></a></li>
<li class="toclevel-1 tocsection-26"><a href="#External_links"><span class="tocnumber">12</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
</div>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Atherosclerosis is often asymptomatic pending grave blockage and narrowing of an artery. Signs and symptoms usually come out when the severe blockage impedes blood flow to different organs.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7"><span>[</span>7<span>]</span></a></sup> Most of the time, patients realize that they have the disease only when they experience other cardio vascular disorders such as stroke or heart attack. These symptoms, however, still vary depending on which artery or organ is affected.<sup id="cite_ref-nhlbi.nih.gov_8-0" class="reference"><a href="#cite_note-nhlbi.nih.gov-8"><span>[</span>8<span>]</span></a></sup> Typically, atherosclerosis begins as a thin layer of white streaks on the artery wall (usually due to white blood cells) and progresses from there. Clinically, atherosclerosis is typically associated with men over the age of 45. Sub-clinically, the disease begins to appear at early childhood, and perhaps even at birth. Noticeable signs can begin developing at puberty. Though symptoms are rarely exhibited in children, early screening of children for cardiovascular diseases could be beneficial to both the child and his/her relatives.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9"><span>[</span>9<span>]</span></a></sup> While coronary artery disease is more prevalent in men than women, atherosclerosis of the cerebral arteries and strokes equally affect both sexes.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup></p>
<p>Blockage in the coronary arteries, which are responsible for bringing oxygenated blood to the heart, can have symptoms such as chest pain of angina and shortness of breath, sweating, nausea, dizziness or light-headedness, breathlessness or palpitations.<sup id="cite_ref-nhlbi.nih.gov_8-1" class="reference"><a href="#cite_note-nhlbi.nih.gov-8"><span>[</span>8<span>]</span></a></sup> Abnormal heart rhythms called arrhythmias, where the heart is either beating too slow or too fast, is also considered a symptom.<sup id="cite_ref-heartandstroke.com_11-0" class="reference"><a href="#cite_note-heartandstroke.com-11"><span>[</span>11<span>]</span></a></sup> Carotid arteries are used to supply blood to the brain and neck.<sup id="cite_ref-heartandstroke.com_11-1" class="reference"><a href="#cite_note-heartandstroke.com-11"><span>[</span>11<span>]</span></a></sup> Blockage in them present symptoms such as a feeling of weakness, not being able to think straight, difficulty in speaking, being dizzy and difficulty in walking or standing up straight, blurred vision, numbness of the face, arms, and legs, severe headache and losing consciousness. These symptoms are also related to stroke. Stroke is caused by blockage of majority arteries going to the brain where lack of oxygen will lead to the death of the cells of the affected tissue.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup> Peripheral arteries, which supply blood to the legs, arms, and pelvis, could also experience blockage due to plaque formation. Symptoms for the blockage here are numbness to the arms or legs, as well at pain. Another significant location for the plaque formation are the renal arteries, which would supply blood to the kidneys. Plaque occurrence and accumulation here could lead to chronic kidney disease, which are asymptomatic at its early stage.<sup id="cite_ref-nhlbi.nih.gov_8-2" class="reference"><a href="#cite_note-nhlbi.nih.gov-8"><span>[</span>8<span>]</span></a></sup></p>
<p>According to United States data for 2004, in about 66% of men and 47% of women, the first symptom of atherosclerotic <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a> is a <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">heart attack</a> or <a href="/wiki/Sudden_cardiac_death" title="Sudden cardiac death">sudden cardiac death</a> (death within one hour of onset of the symptom). <a href="/wiki/Cardiac_stress_test" title="Cardiac stress test">Cardiac stress testing</a>, traditionally the most commonly performed non-invasive testing method for blood flow limitations, in general, detects only <a href="/wiki/Lumen_(anatomy)" title="Lumen (anatomy)">lumen</a> narrowing of ~75% or greater, although some physicians claim that nuclear stress methods can detect as little as 50%.</p>
<p>Case studies have included autopsies of American soldiers killed in <a href="/wiki/World_War_II" title="World War II">World War II</a> and the <a href="/wiki/Korean_War" title="Korean War">Korean War</a>. A much-cited report involved autopsies of 300 American soldiers killed in Korea. Although the average age of the men was 22.1 years, 77.3 percent had "gross evidence of coronary arteriosclerosis."<sup id="cite_ref-Enos_13-0" class="reference"><a href="#cite_note-Enos-13"><span>[</span>13<span>]</span></a></sup> Other studies done of soldiers in the <a href="/wiki/Vietnam_War" title="Vietnam War">Second Indochina War</a> showed similar results, although often worse than the ones from the earlier wars. Theories include high rates of <a href="/wiki/Tobacco_use" title="Tobacco use" class="mw-redirect">tobacco use</a> and (in the case of the Vietnam soldiers) the advent of processed foods after WWII.</p>
<h2><span class="mw-headline" id="Causes">Causes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=2" title="Edit section: Causes">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table class="metadata plainlinks ambox ambox-content ambox-Refimprove" role="presentation">
<tr>
<td class="mbox-image">
<div style="width:52px;"><a href="/wiki/File:Question_book-new.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png" width="50" height="39" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x" /></a></div>
</td>
<td class="mbox-text"><span class="mbox-text-span">This section <b>needs additional citations for <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">verification</a></b>. <span class="hide-when-compact">Please help <a class="external text" href="//en.wikipedia.org/w/index.php?title=Atherosclerosis&amp;action=edit">improve this article</a> by <a href="/wiki/Help:Introduction_to_referencing/1" title="Help:Introduction to referencing/1">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span> <small><i>(October 2013)</i></small></span></td>
</tr>
</table>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Blausen_0227_Cholesterol.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0e/Blausen_0227_Cholesterol.png/220px-Blausen_0227_Cholesterol.png" width="220" height="236" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/0e/Blausen_0227_Cholesterol.png/330px-Blausen_0227_Cholesterol.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/0e/Blausen_0227_Cholesterol.png/440px-Blausen_0227_Cholesterol.png 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Blausen_0227_Cholesterol.png" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Atherosclerosis and lipoproteins</div>
</div>
</div>
<div class="rellink boilerplate seealso">See also: <a href="/wiki/Lipoprotein" title="Lipoprotein">Lipoprotein</a></div>
<p>The atherosclerotic process is not fully understood. Atherosclerosis is initiated by inflammatory processes in the endothelial cells of the vessel wall in response to retained <a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">low-density lipoprotein</a> (LDL) molecules.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14"><span>[</span>14<span>]</span></a></sup></p>
<p>Lipoproteins in the blood vary in size. Some data suggests that only small dense LDL (sdLDL) particles are able to get behind the cellular monolayer of <a href="/wiki/Endothelium" title="Endothelium">endothelium</a>. LDL particles and their content are susceptible to oxidation by <a href="/wiki/Radical_(chemistry)" title="Radical (chemistry)">free radicals</a>,<sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup> and the risk may be higher while in the bloodstream. However, LDL particles have a <a href="/wiki/Half-life" title="Half-life">half-life</a> of only a couple of days, and their content (LDL particles carry cholesterol, cholesteryl esters, and tryglycerides from the liver to the tissues of the body) changes with time.</p>
<p>Once inside the vessel wall, LDL particles get stuck and their content becomes more prone to oxidation. The damage caused by the oxidized LDL molecules triggers a cascade of immune responses which over time can produce an atheroma. First the immune system sends specialized white blood cells (<a href="/wiki/Macrophages" title="Macrophages" class="mw-redirect">macrophages</a> and <a href="/wiki/T-lymphocytes" title="T-lymphocytes" class="mw-redirect">T-lymphocytes</a>) to absorb the oxidized LDL, forming specialized <a href="/wiki/Foam_cells" title="Foam cells" class="mw-redirect">foam cells</a>. These white blood cells are not able to process the oxidized LDL. They grow and then rupture, depositing a greater amount of oxidized cholesterol into the artery wall. This triggers more white blood cells, continuing the cycle. Eventually, the artery becomes inflamed. The cholesterol plaque causes the muscle cells to enlarge and form a hard cover over the affected area. This hard cover is what causes a narrowing of the artery, reducing blood flow and increasing blood pressure.</p>
<p>Some researchers believe that atherosclerosis may be caused by an infection of the vascular smooth muscle cells. Chickens, for example, develop atherosclerosis when infected with the <a href="/wiki/Marek%27s_disease" title="Marek's disease">Marek's disease</a> herpesvirus.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span>[</span>16<span>]</span></a></sup> <a href="/wiki/Herpesvirus" title="Herpesvirus" class="mw-redirect">Herpesvirus</a> infection of arterial <a href="/wiki/Smooth_muscle_cells" title="Smooth muscle cells" class="mw-redirect">smooth muscle cells</a> has been shown to cause cholesteryl ester (CE) accumulation, which is associated with atherosclerosis.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17"><span>[</span>17<span>]</span></a></sup> <a href="/wiki/Cytomegalovirus" title="Cytomegalovirus">Cytomegalovirus</a> (CMV) infection is also associated with cardiovascular diseases.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Risk_factors">Risk factors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=3" title="Edit section: Risk factors">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Various anatomic and physiological risk factors for atherosclerosis are known.<sup id="cite_ref-Blankenhorn_19-0" class="reference"><a href="#cite_note-Blankenhorn-19"><span>[</span>19<span>]</span></a></sup> These can be divided into various categories: congenital <i>vs</i> acquired, modifiable or not, classical or non-classical. The points labelled '+' in the following list form the core components of <a href="/wiki/Metabolic_syndrome" title="Metabolic syndrome">metabolic syndrome</a>.</p>
<p>Risks multiply, with two factors increasing the risk of atherosclerosis fourfold.<sup id="cite_ref-Kumar345_20-0" class="reference"><a href="#cite_note-Kumar345-20"><span>[</span>20<span>]</span></a></sup> Hyperlipidemia, hypertension and cigarette smoking together increases the risk seven times.<sup id="cite_ref-Kumar345_20-1" class="reference"><a href="#cite_note-Kumar345-20"><span>[</span>20<span>]</span></a></sup></p>
<h4><span class="mw-headline" id="Modifiable">Modifiable</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=4" title="Edit section: Modifiable">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<ul>
<li><a href="/wiki/Diabetes" title="Diabetes" class="mw-redirect">Diabetes</a><sup id="cite_ref-Kumar345_20-2" class="reference"><a href="#cite_note-Kumar345-20"><span>[</span>20<span>]</span></a></sup> or <a href="/wiki/Impaired_glucose_tolerance" title="Impaired glucose tolerance">Impaired glucose tolerance</a> (IGT) +</li>
<li><a href="/wiki/Lipoprotein" title="Lipoprotein">Dyslipoproteinemia</a><sup id="cite_ref-Kumar345_20-3" class="reference"><a href="#cite_note-Kumar345-20"><span>[</span>20<span>]</span></a></sup> (unhealthy patterns of serum proteins carrying fats &amp; <a href="/wiki/Cholesterol" title="Cholesterol">cholesterol</a>): +
<ul>
<li>High serum concentration of <a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">low-density lipoprotein</a> (LDL, "bad if elevated concentrations and small"), and / or <a href="/wiki/Very_low_density_lipoprotein" title="Very low density lipoprotein" class="mw-redirect">very low density lipoprotein</a> (VLDL) particles, i.e., "lipoprotein subclass analysis"</li>
<li>Low serum concentration of functioning <a href="/wiki/High_density_lipoprotein" title="High density lipoprotein" class="mw-redirect">high density lipoprotein</a> (HDL "protective if large and high enough" particles), i.e., "lipoprotein subclass analysis"</li>
<li>An LDL:HDL ratio greater than 3:1</li>
</ul>
</li>
<li><a href="/wiki/Tobacco_smoking" title="Tobacco smoking">Tobacco smoking</a>, increases risk by 200% after several <a href="/wiki/Pack_year" title="Pack year" class="mw-redirect">pack years</a><sup id="cite_ref-Kumar345_20-4" class="reference"><a href="#cite_note-Kumar345-20"><span>[</span>20<span>]</span></a></sup></li>
<li>Elevated serum <a href="/wiki/C-reactive_protein" title="C-reactive protein">C-reactive protein</a> concentrations<sup id="cite_ref-Kumar345_20-5" class="reference"><a href="#cite_note-Kumar345-20"><span>[</span>20<span>]</span></a></sup><sup id="cite_ref-21" class="reference"><a href="#cite_note-21"><span>[</span>21<span>]</span></a></sup></li>
<li>Vitamin B<sub>6</sub> deficiency<sup id="cite_ref-22" class="reference"><a href="#cite_note-22"><span>[</span>22<span>]</span></a></sup><sup id="cite_ref-23" class="reference"><a href="#cite_note-23"><span>[</span>23<span>]</span></a></sup><sup id="cite_ref-24" class="reference"><a href="#cite_note-24"><span>[</span>24<span>]</span></a></sup></li>
<li>Dietary <a href="/wiki/Iodine_deficiency" title="Iodine deficiency">iodine deficiency</a> and <a href="/wiki/Hypothyroidism" title="Hypothyroidism">hypothyroidism</a>, which cause <a href="/wiki/Elevated_serum_cholesterol" title="Elevated serum cholesterol" class="mw-redirect">elevated serum cholesterol</a> and of <a href="/wiki/Lipid_peroxidation" title="Lipid peroxidation">lipid peroxidation</a><sup id="cite_ref-Kocher_T_1883_254.E2.80.93337_25-0" class="reference"><a href="#cite_note-Kocher_T_1883_254.E2.80.93337-25"><span>[</span>25<span>]</span></a></sup><sup id="cite_ref-Turner_KB_1933_115.E2.80.93125_26-0" class="reference"><a href="#cite_note-Turner_KB_1933_115.E2.80.93125-26"><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-Katamine_S.2C_Hoshino_N.2C_Totsuka_K.2C_Suzuki_M._1985_339.E2.80.93345_27-0" class="reference"><a href="#cite_note-Katamine_S.2C_Hoshino_N.2C_Totsuka_K.2C_Suzuki_M._1985_339.E2.80.93345-27"><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-Cann_SA_2006_1.E2.80.9311_28-0" class="reference"><a href="#cite_note-Cann_SA_2006_1.E2.80.9311-28"><span>[</span>28<span>]</span></a></sup><sup id="cite_ref-Venturi.2C_Sebastiano_2011_155.E2.80.93162_29-0" class="reference"><a href="#cite_note-Venturi.2C_Sebastiano_2011_155.E2.80.93162-29"><span>[</span>29<span>]</span></a></sup></li>
</ul>
<h4><span class="mw-headline" id="Nonmodifiable">Nonmodifiable</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=5" title="Edit section: Nonmodifiable">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<ul>
<li><a href="/wiki/Senescence" title="Senescence">Advanced age</a><sup id="cite_ref-Kumar345_20-6" class="reference"><a href="#cite_note-Kumar345-20"><span>[</span>20<span>]</span></a></sup></li>
<li><a href="/wiki/Male" title="Male">Male</a> sex<sup id="cite_ref-Kumar345_20-7" class="reference"><a href="#cite_note-Kumar345-20"><span>[</span>20<span>]</span></a></sup></li>
<li>Having close relatives who have had some complication of atherosclerosis (e.g. <a href="/wiki/Coronary_heart_disease" title="Coronary heart disease" class="mw-redirect">coronary heart disease</a> or <a href="/wiki/Stroke" title="Stroke">stroke</a>)<sup id="cite_ref-Kumar345_20-8" class="reference"><a href="#cite_note-Kumar345-20"><span>[</span>20<span>]</span></a></sup></li>
<li>Genetic abnormalities,<sup id="cite_ref-Kumar345_20-9" class="reference"><a href="#cite_note-Kumar345-20"><span>[</span>20<span>]</span></a></sup> e.g. <a href="/wiki/Familial_hypercholesterolemia" title="Familial hypercholesterolemia">familial hypercholesterolemia</a></li>
</ul>
<h4><span class="mw-headline" id="Lesser_or_uncertain">Lesser or uncertain</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=6" title="Edit section: Lesser or uncertain">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>The following factors are of relatively lesser importance, are uncertain or unquantified:</p>
<ul>
<li><a href="/wiki/Obesity" title="Obesity">Obesity</a><sup id="cite_ref-Kumar345_20-10" class="reference"><a href="#cite_note-Kumar345-20"><span>[</span>20<span>]</span></a></sup> (in particular <a href="/wiki/Central_obesity" title="Central obesity" class="mw-redirect">central obesity</a>, also referred to as <i>abdominal</i> or <i>male-type</i> obesity) +</li>
<li>Hypercoagulability<sup id="cite_ref-30" class="reference"><a href="#cite_note-30"><span>[</span>30<span>]</span></a></sup><sup id="cite_ref-31" class="reference"><a href="#cite_note-31"><span>[</span>31<span>]</span></a></sup><sup id="cite_ref-32" class="reference"><a href="#cite_note-32"><span>[</span>32<span>]</span></a></sup></li>
<li><a href="/wiki/Postmenopausal_estrogen_deficiency" title="Postmenopausal estrogen deficiency" class="mw-redirect">Postmenopausal estrogen deficiency</a><sup id="cite_ref-Kumar345_20-11" class="reference"><a href="#cite_note-Kumar345-20"><span>[</span>20<span>]</span></a></sup></li>
<li>High intake of <a href="/wiki/Saturated_fat" title="Saturated fat">saturated fat</a> (may raise total and LDL cholesterol)<sup id="cite_ref-33" class="reference"><a href="#cite_note-33"><span>[</span>33<span>]</span></a></sup></li>
<li>Intake of <a href="/wiki/Trans_fat" title="Trans fat">trans fat</a> (may raise total and LDL cholesterol while lowering HDL cholesterol)<sup id="cite_ref-Kumar345_20-12" class="reference"><a href="#cite_note-Kumar345-20"><span>[</span>20<span>]</span></a></sup><sup id="cite_ref-34" class="reference"><a href="#cite_note-34"><span>[</span>34<span>]</span></a></sup></li>
<li>High <a href="/wiki/Carbohydrate" title="Carbohydrate">carbohydrate</a> intake<sup id="cite_ref-Kumar345_20-13" class="reference"><a href="#cite_note-Kumar345-20"><span>[</span>20<span>]</span></a></sup></li>
<li>Elevated serum levels of <a href="/wiki/Triglycerides" title="Triglycerides" class="mw-redirect">triglycerides</a> +</li>
<li>Elevated serum levels of <a href="/wiki/Homocysteine" title="Homocysteine">homocysteine</a></li>
<li>Elevated serum levels of <a href="/wiki/Uric_acid" title="Uric acid">uric acid</a> (also responsible for <a href="/wiki/Gout" title="Gout">gout</a>)</li>
<li>Elevated serum <a href="/wiki/Fibrinogen" title="Fibrinogen">fibrinogen</a> concentrations</li>
<li>Elevated serum <a href="/wiki/Lipoprotein(a)" title="Lipoprotein(a)">lipoprotein(a)</a> concentrations<sup id="cite_ref-Kumar345_20-14" class="reference"><a href="#cite_note-Kumar345-20"><span>[</span>20<span>]</span></a></sup></li>
<li>Chronic systemic <a href="/wiki/Inflammation" title="Inflammation">inflammation</a> as reflected by upper normal WBC concentrations, elevated <a href="/wiki/C_reactive_protein" title="C reactive protein" class="mw-redirect">hs-CRP</a> and many other blood chemistry markers, most only research level at present, not clinically done.<sup id="cite_ref-Bhatt_35-0" class="reference"><a href="#cite_note-Bhatt-35"><span>[</span>35<span>]</span></a></sup></li>
<li><a href="/wiki/Hyperthyroidism" title="Hyperthyroidism">Hyperthyroidism</a> (an over-active <a href="/wiki/Thyroid" title="Thyroid">thyroid</a>)</li>
<li>Elevated serum insulin levels +<sup id="cite_ref-Hyperinsulinaemia_36-0" class="reference"><a href="#cite_note-Hyperinsulinaemia-36"><span>[</span>36<span>]</span></a></sup></li>
<li>Short sleep duration<sup id="cite_ref-37" class="reference"><a href="#cite_note-37"><span>[</span>37<span>]</span></a></sup></li>
<li><i><a href="/wiki/Chlamydia_pneumoniae" title="Chlamydia pneumoniae" class="mw-redirect">Chlamydia pneumoniae</a></i> infection<sup id="cite_ref-Kumar345_20-15" class="reference"><a href="#cite_note-Kumar345-20"><span>[</span>20<span>]</span></a></sup></li>
<li><a href="/wiki/PM2.5" title="PM2.5" class="mw-redirect">PM<sub>2.5</sub></a> air pollution, fine particulates less than 2.5&#160;<a href="/wiki/%CE%9Cm" title="Μm" class="mw-redirect">µm</a> in diameter, have been associated with thickening of the <a href="/wiki/Carotid_artery" title="Carotid artery">carotid artery</a>.<sup id="cite_ref-PLoSMed42313_38-0" class="reference"><a href="#cite_note-PLoSMed42313-38"><span>[</span>38<span>]</span></a></sup></li>
</ul>
<h4><span class="mw-headline" id="Dietary">Dietary</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=7" title="Edit section: Dietary">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>The relation between dietary fat and atherosclerosis is a contentious field. The <a href="/wiki/United_States_Department_of_Agriculture" title="United States Department of Agriculture">USDA</a>, in its <a href="/wiki/Food_guide_pyramid" title="Food guide pyramid">food pyramid</a>, promotes a <a href="/wiki/Low-fat_diet" title="Low-fat diet">low-fat diet</a>, based largely on its view that fat in the diet is atherogenic. The <a href="/wiki/American_Heart_Association" title="American Heart Association">American Heart Association</a>, the <a href="/wiki/American_Diabetes_Association" title="American Diabetes Association">American Diabetes Association</a> and the <a href="/wiki/National_Cholesterol_Education_Program" title="National Cholesterol Education Program">National Cholesterol Education Program</a> make similar recommendations. In contrast, Prof <a href="/wiki/Walter_Willett" title="Walter Willett">Walter Willett</a> (Harvard School of Public Health, <a href="/wiki/Principal_investigator" title="Principal investigator">PI</a> of the second <a href="/wiki/Nurses%27_Health_Study" title="Nurses' Health Study">Nurses' Health Study</a>) recommends much higher levels, especially of <a href="/wiki/Monounsaturated_fat" title="Monounsaturated fat">monounsaturated</a> and <a href="/wiki/Polyunsaturated_fat" title="Polyunsaturated fat">polyunsaturated fat</a>.<sup id="cite_ref-titleFood_Pyramids:_Nutrition_Source.2C_Harvard_School_of_Public_Health_39-0" class="reference"><a href="#cite_note-titleFood_Pyramids:_Nutrition_Source.2C_Harvard_School_of_Public_Health-39"><span>[</span>39<span>]</span></a></sup> Writing in <i><a href="/wiki/Science" title="Science">Science</a></i>, <a href="/wiki/Gary_Taubes" title="Gary Taubes">Gary Taubes</a> detailed that political considerations played into the recommendations of government bodies.<sup id="cite_ref-Taubes_40-0" class="reference"><a href="#cite_note-Taubes-40"><span>[</span>40<span>]</span></a></sup> These differing views reach a consensus, though, against consumption of <a href="/wiki/Trans_fat" title="Trans fat">trans fats</a>.</p>
<p>The role of dietary oxidized fats/<a href="/wiki/Lipid_peroxidation" title="Lipid peroxidation">lipid peroxidation</a> (<a href="/wiki/Rancidification" title="Rancidification">rancid fats</a>) in humans is not clear. Laboratory animals fed rancid fats develop atherosclerosis. Rats fed <a href="/wiki/Docosahexaenoic_acid" title="Docosahexaenoic acid">DHA</a>-containing oils experienced marked disruptions to their <a href="/wiki/Antioxidant" title="Antioxidant">antioxidant</a> systems, and accumulated significant amounts of <a href="/wiki/Phospholipid" title="Phospholipid">phospholipid</a> <a href="/wiki/Hydroperoxide" title="Hydroperoxide" class="mw-redirect">hydroperoxide</a> in their blood, livers and kidneys.<sup id="cite_ref-SongJH_41-0" class="reference"><a href="#cite_note-SongJH-41"><span>[</span>41<span>]</span></a></sup> In another study, rabbits fed atherogenic diets containing various oils were found to undergo the greatest amount of oxidative susceptibility of LDL via polyunsaturated oils.<sup id="cite_ref-YapSC_42-0" class="reference"><a href="#cite_note-YapSC-42"><span>[</span>42<span>]</span></a></sup> In a study involving rabbits fed heated soybean oil, "grossly induced atherosclerosis and marked liver damage were histologically and clinically demonstrated."<sup id="cite_ref-Greco_43-0" class="reference"><a href="#cite_note-Greco-43"><span>[</span>43<span>]</span></a></sup> However, Kummerow, a prominent researcher, claims that it is not dietary cholesterol, but oxysterols, or oxidized cholesterols, from fried foods and smoking, that are the culprit.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44"><span>[</span>44<span>]</span></a></sup></p>
<p>Rancid fats and oils taste very bad even in small amounts, so people avoid eating them.<sup id="cite_ref-pmid16249011_45-0" class="reference"><a href="#cite_note-pmid16249011-45"><span>[</span>45<span>]</span></a></sup> It is very difficult to measure or estimate the actual human consumption of these substances.<sup id="cite_ref-pmid12589185_46-0" class="reference"><a href="#cite_note-pmid12589185-46"><span>[</span>46<span>]</span></a></sup></p>
<p>Highly unsaturated omega-3 rich oils such as fish oil are being sold in pill form so that the taste of oxidized or rancid fat is not apparent. The health food industry's dietary supplements are self regulated by the manufacture and outside of FDA regulations.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47"><span>[</span>47<span>]</span></a></sup> To properly protect unsaturated fats from oxidation, it is best to keep them cool and in oxygen free environments. Long term exposure to inorganic arsenic can cause atherosclerosis.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48"><span>[</span>48<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=8" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Atherogenesis is the developmental process of atheromatous plaques. It is characterized by a remodeling of arteries leading to subendothelial accumulation of fatty substances called plaques. The build up of an atheromatous plaque is a slow process, developed over a period of several years through a complex series of cellular events occurring within the arterial wall, and in response to a variety of local vascular circulating factors. One recent hypothesis suggests that, for unknown reasons, <a href="/wiki/Leukocytes" title="Leukocytes" class="mw-redirect">leukocytes</a>, such as <a href="/wiki/Monocytes" title="Monocytes" class="mw-redirect">monocytes</a> or <a href="/wiki/Basophils" title="Basophils" class="mw-redirect">basophils</a>, begin to attack the <a href="/wiki/Endothelium" title="Endothelium">endothelium</a> of the artery lumen in <a href="/wiki/Cardiac_muscle" title="Cardiac muscle">cardiac muscle</a>. The ensuing <a href="/wiki/Inflammation" title="Inflammation">inflammation</a> leads to formation of atheromatous plaques in the arterial <a href="/wiki/Tunica_intima" title="Tunica intima">tunica intima</a>, a region of the vessel wall located between the <a href="/wiki/Endothelium" title="Endothelium">endothelium</a> and the <a href="/wiki/Tunica_media" title="Tunica media">tunica media</a>. The bulk of these lesions is made of excess fat, <a href="/wiki/Collagen" title="Collagen">collagen</a>, and <a href="/wiki/Elastin" title="Elastin">elastin</a>. At first, as the plaques grow, only <a href="/wiki/Intima-media_thickness" title="Intima-media thickness">wall thickening</a> occurs without any narrowing. <a href="/wiki/Stenosis" title="Stenosis">Stenosis</a> is a late event, which may never occur and is often the result of repeated plaque rupture and healing responses, not just the atherosclerotic process by itself.</p>
<h3><span class="mw-headline" id="Cellular">Cellular</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=9" title="Edit section: Cellular">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:RCA_atherosclerosis.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/f2/RCA_atherosclerosis.jpg/220px-RCA_atherosclerosis.jpg" width="220" height="186" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/f2/RCA_atherosclerosis.jpg/330px-RCA_atherosclerosis.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f2/RCA_atherosclerosis.jpg/440px-RCA_atherosclerosis.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:RCA_atherosclerosis.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
<a href="/wiki/Micrograph" title="Micrograph">Micrograph</a> of an <a href="/wiki/Right_coronary_artery" title="Right coronary artery">artery</a> that supplies the <a href="/wiki/Heart" title="Heart">heart</a> showing significant atherosclerosis and marked <a href="/wiki/Lumen_(anatomy)" title="Lumen (anatomy)">luminal</a> narrowing. Tissue has been stained using <a href="/wiki/Masson%27s_trichrome" title="Masson's trichrome" class="mw-redirect">Masson's trichrome</a>.</div>
</div>
</div>
<p>Early atherogenesis is characterized by the adherence of blood circulating <a href="/wiki/Monocytes" title="Monocytes" class="mw-redirect">monocytes</a> (a type of <a href="/wiki/White_blood_cell" title="White blood cell">white blood cell</a>) to the vascular bed lining, the <a href="/wiki/Endothelium" title="Endothelium">endothelium</a>, then by their migration to the sub-endothelial space, and further activation into monocyte-derived <a href="/wiki/Macrophages" title="Macrophages" class="mw-redirect">macrophages</a>.<sup id="cite_ref-49" class="reference"><a href="#cite_note-49"><span>[</span>49<span>]</span></a></sup> The primary documented driver of this process is oxidized lipoprotein particles within the wall, beneath the <a href="/wiki/Endothelium" title="Endothelium">endothelial</a> cells, though upper normal or elevated concentrations of blood glucose also plays a major role and not all factors are fully understood. Fatty streaks may appear and disappear.</p>
<p><a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">Low-density lipoprotein</a> (LDL) particles in blood plasma invade the <a href="/wiki/Endothelium" title="Endothelium">endothelium</a> and become oxidized, creating risk of <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a>. A complex set of biochemical reactions regulates the oxidation of LDL, involving enzymes (such as <a href="/wiki/Lp-LpA2" title="Lp-LpA2">Lp-LpA2</a>) and <a href="/wiki/Free_radical" title="Free radical" class="mw-redirect">free radicals</a> in the endothelium.</p>
<p>Initial damage to the endothelium results in an inflammatory response. Monocytes enter the artery wall from the bloodstream, with <a href="/wiki/Platelet" title="Platelet">platelets</a> adhering to the area of insult. This may be promoted by <a href="/wiki/Redox_signaling" title="Redox signaling" class="mw-redirect">redox signaling</a> induction of factors such as <a href="/wiki/VCAM-1" title="VCAM-1">VCAM-1</a>, which recruit circulating monocytes, and <a href="/wiki/M-CSF" title="M-CSF" class="mw-redirect">M-CSF</a>, which is selectively required for the differentiation of monocytes to macrophages. The monocytes differentiate into <a href="/wiki/Macrophage" title="Macrophage">macrophages</a>, which ingest oxidized LDL, slowly turning into large "foam cells" – so-called because of their changed appearance resulting from the numerous internal cytoplasmic <a href="/wiki/Vesicle_(biology)" title="Vesicle (biology)" class="mw-redirect">vesicles</a> and resulting high <a href="/wiki/Lipid" title="Lipid">lipid</a> content. Under the microscope, the lesion now appears as a fatty streak. Foam cells eventually die, and further propagate the inflammatory process. There is also smooth muscle proliferation and migration from the <a href="/wiki/Tunica_media" title="Tunica media">tunica media</a> into the <a href="/wiki/Tunica_intima" title="Tunica intima">intima</a> responding to <a href="/wiki/Cytokines" title="Cytokines" class="mw-redirect">cytokines</a> secreted by damaged endothelial cells. This causes the formation of a fibrous capsule covering the fatty streak. Intact endothelium could prevent the proliferation by releasing nitric oxide.</p>
<h3><span class="mw-headline" id="Calcification_and_lipids">Calcification and lipids</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=10" title="Edit section: Calcification and lipids">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Calcification" title="Calcification">Calcification</a><sup id="cite_ref-:0_2-1" class="reference"><a href="#cite_note-:0-2"><span>[</span>2<span>]</span></a></sup> forms among <a href="/wiki/Vascular_smooth_muscle" title="Vascular smooth muscle">vascular smooth muscle</a> cells of the surrounding muscular layer, specifically in the muscle cells adjacent to atheromas and on the surface of atheroma plaques and tissue.<sup id="cite_ref-:0_2-2" class="reference"><a href="#cite_note-:0-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-:1_3-1" class="reference"><a href="#cite_note-:1-3"><span>[</span>3<span>]</span></a></sup> In time, as cells die, this leads to extracellular calcium deposits between the muscular wall and outer portion of the atheromatous plaques. With the atheromatous plaque interfering with the regulation of the calcium deposition, it accumulates and crystallizes. A similar form of an intramural calcification, presenting the picture of an early phase of arteriosclerosis, appears to be induced by a number of drugs that have an antiproliferative mechanism of action (<a href="/wiki/Rainer_Liedtke" title="Rainer Liedtke">Rainer Liedtke</a> 2008).</p>
<p>Cholesterol is delivered into the vessel wall by cholesterol-containing <a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">low-density lipoprotein</a> (LDL) particles. To attract and stimulate macrophages, the cholesterol must be released from the LDL particles and oxidized, a key step in the ongoing inflammatory process. The process is worsened if there is insufficient <a href="/wiki/High-density_lipoprotein" title="High-density lipoprotein">high-density lipoprotein</a> (HDL), the lipoprotein particle that removes cholesterol from tissues and carries it back to the liver.</p>
<p>The foam cells and platelets encourage the migration and proliferation of <a href="/wiki/Smooth_muscle" title="Smooth muscle" class="mw-redirect">smooth muscle</a> cells, which in turn ingest lipids, become replaced by collagen and transform into foam cells themselves. A protective fibrous cap normally forms between the fatty deposits and the artery lining (the <a href="/wiki/Endothelium" title="Endothelium">intima</a>).</p>
<p>These capped fatty deposits (now called 'atheromas') produce enzymes that cause the artery to enlarge over time. As long as the artery enlarges sufficiently to compensate for the extra thickness of the atheroma, then no narrowing ("<a href="/wiki/Stenosis" title="Stenosis">stenosis</a>") of the opening ("lumen") occurs. The artery becomes expanded with an egg-shaped cross-section, still with a circular opening. If the enlargement is beyond proportion to the atheroma thickness, then an <a href="/wiki/Aneurysm" title="Aneurysm">aneurysm</a> is created.<sup id="cite_ref-Glagov_50-0" class="reference"><a href="#cite_note-Glagov-50"><span>[</span>50<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Visible_features">Visible features</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=11" title="Edit section: Visible features">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:232px;"><a href="/wiki/File:Atherosclerosis,_aorta,_gross_pathology_PHIL_846_lores.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Atherosclerosis%2C_aorta%2C_gross_pathology_PHIL_846_lores.jpg/230px-Atherosclerosis%2C_aorta%2C_gross_pathology_PHIL_846_lores.jpg" width="230" height="358" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Atherosclerosis%2C_aorta%2C_gross_pathology_PHIL_846_lores.jpg/345px-Atherosclerosis%2C_aorta%2C_gross_pathology_PHIL_846_lores.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Atherosclerosis%2C_aorta%2C_gross_pathology_PHIL_846_lores.jpg/460px-Atherosclerosis%2C_aorta%2C_gross_pathology_PHIL_846_lores.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Atherosclerosis,_aorta,_gross_pathology_PHIL_846_lores.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Severe atherosclerosis of the <a href="/wiki/Aorta" title="Aorta">aorta</a>. <a href="/wiki/Autopsy" title="Autopsy">Autopsy</a> specimen.</div>
</div>
</div>
<p>Although arteries are not typically studied microscopically, two plaque types can be distinguished:<sup id="cite_ref-51" class="reference"><a href="#cite_note-51"><span>[</span>51<span>]</span></a></sup></p>
<ol>
<li>The <b>fibro-lipid (fibro-fatty) plaque</b> is characterized by an accumulation of lipid-laden cells underneath the intima of the arteries, typically without narrowing the lumen due to compensatory expansion of the bounding muscular layer of the artery wall. Beneath the endothelium there is a "fibrous cap" covering the atheromatous "core" of the plaque. The core consists of lipid-laden cells (macrophages and smooth muscle cells) with elevated tissue cholesterol and cholesterol ester content, fibrin, proteoglycans, collagen, elastin, and cellular debris. In advanced plaques, the central core of the plaque usually contains extracellular cholesterol deposits (released from dead cells), which form areas of cholesterol crystals with empty, needle-like clefts. At the periphery of the plaque are younger "foamy" cells and capillaries. These plaques usually produce the most damage to the individual when they rupture.</li>
<li>The <b>fibrous plaque</b> is also localized under the intima, within the wall of the artery resulting in thickening and expansion of the wall and, sometimes, spotty localized narrowing of the lumen with some atrophy of the muscular layer. The fibrous plaque contains collagen fibers (eosinophilic), precipitates of calcium (hematoxylinophilic) and, rarely, lipid-laden cells.</li>
</ol>
<p>In effect, the muscular portion of the artery wall forms small <a href="/wiki/Aneurysm" title="Aneurysm">aneurysms</a> just large enough to hold the <a href="/wiki/Atheroma" title="Atheroma">atheroma</a> that are present. The muscular portion of artery walls usually remain strong, even after they have remodeled to compensate for the atheromatous plaques.</p>
<p>However, atheromas within the vessel wall are soft and fragile with little elasticity. Arteries constantly expand and contract with each heartbeat, i.e., the pulse. In addition, the calcification deposits between the outer portion of the atheroma and the muscular wall, as they progress, lead to a loss of elasticity and stiffening of the artery as a whole.</p>
<p>The calcification deposits,<sup id="cite_ref-:0_2-3" class="reference"><a href="#cite_note-:0-2"><span>[</span>2<span>]</span></a></sup> after they have become sufficiently advanced, are partially visible on coronary artery <a href="/wiki/Computed_tomography" title="Computed tomography" class="mw-redirect">computed tomography</a> or <a href="/wiki/Electron_beam_tomography" title="Electron beam tomography">electron beam tomography</a> (EBT) as rings of increased radiographic density, forming halos around the outer edges of the atheromatous plaques, within the artery wall. On CT, &gt;130 units on the <a href="/wiki/Hounsfield_scale" title="Hounsfield scale">Hounsfield scale</a> (some argue for 90 units) has been the radiographic density usually accepted as clearly representing tissue calcification within arteries. These deposits demonstrate unequivocal evidence of the disease, relatively advanced, even though the lumen of the artery is often still normal by angiographic or <a href="/wiki/Intravascular_ultrasound" title="Intravascular ultrasound">intravascular ultrasound</a>.</p>
<h3><span class="mw-headline" id="Rupture_and_stenosis">Rupture and stenosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=12" title="Edit section: Rupture and stenosis">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Although the disease process tends to be slowly progressive over decades, it usually remains asymptomatic until an atheroma <a href="//en.wiktionary.org/wiki/ulcer" class="extiw" title="wiktionary:ulcer">ulcerates</a>, which leads to immediate blood clotting at the site of atheroma ulcer. This triggers a cascade of events that leads to clot enlargement, which may quickly obstruct the flow of blood. A complete blockage leads to ischemia of the myocardial (heart) muscle and damage. This process is the myocardial infarction or "heart attack".</p>
<p>If the heart attack is not fatal, fibrous organization of the clot within the lumen ensues, covering the rupture but also producing <a href="/wiki/Stenosis" title="Stenosis">stenosis</a> or closure of the lumen, or over time and after repeated ruptures, resulting in a persistent, usually localized stenosis or blockage of the artery lumen. Stenoses can be slowly progressive, whereas plaque ulceration is a sudden event that occurs specifically in atheromas with thinner/weaker fibrous caps that have become "unstable".</p>
<p>Repeated plaque ruptures, ones not resulting in total lumen closure, combined with the clot patch over the rupture and healing response to stabilize the clot, is the process that produces most stenoses over time. The stenotic areas tend to become more stable, despite increased flow velocities at these narrowings. Most major blood-flow-stopping events occur at large plaques, which, prior to their rupture, produced very little if any stenosis.</p>
<p>From clinical trials, 20% is the average stenosis at plaques that subsequently rupture with resulting complete artery closure. Most severe clinical events do not occur at plaques that produce high-grade stenosis. From clinical trials, only 14% of heart attacks occur from artery closure at plaques producing a 75% or greater stenosis prior to the vessel closing.<sup class="Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (August 2010)">citation needed</span></a></i>]</sup></p>
<p>If the fibrous cap separating a soft atheroma from the bloodstream within the artery ruptures, tissue fragments are exposed and released. These tissue fragments are very clot-promoting, containing <a href="/wiki/Collagen" title="Collagen">collagen</a> and <a href="/wiki/Tissue_factor" title="Tissue factor">tissue factor</a>; they activate <a href="/wiki/Platelet" title="Platelet">platelets</a> and activate the <a href="/wiki/Coagulation" title="Coagulation">system of coagulation</a>. The result is the formation of a <a href="/wiki/Thrombus" title="Thrombus">thrombus</a> (blood clot) overlying the atheroma, which obstructs blood flow acutely. With the obstruction of blood flow, downstream tissues are starved of <a href="/wiki/Oxygen" title="Oxygen">oxygen</a> and nutrients. If this is the <a href="/wiki/Myocardium" title="Myocardium" class="mw-redirect">myocardium</a> (heart muscle), <a href="/wiki/Angina_pectoris" title="Angina pectoris">angina</a> (cardiac chest pain) or <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a> (heart attack) develops.</p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=13" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Calcificatio_atherosclerotica.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/49/Calcificatio_atherosclerotica.jpg/220px-Calcificatio_atherosclerotica.jpg" width="220" height="177" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/49/Calcificatio_atherosclerotica.jpg/330px-Calcificatio_atherosclerotica.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/49/Calcificatio_atherosclerotica.jpg/440px-Calcificatio_atherosclerotica.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Calcificatio_atherosclerotica.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Microphotography of arterial wall with calcified (violet colour) atherosclerotic plaque (haematoxillin &amp; eosin stain)</div>
</div>
</div>
<p>Areas of severe narrowing, <a href="/wiki/Stenosis" title="Stenosis">stenosis</a>, detectable by <a href="/wiki/Angiography" title="Angiography">angiography</a>, and to a lesser extent "<a href="/wiki/Cardiac_stress_test" title="Cardiac stress test">stress testing</a>" have long been the focus of human diagnostic techniques for <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a>, in general. However, these methods focus on detecting only severe narrowing, not the underlying atherosclerosis disease. As demonstrated by human clinical studies, most severe events occur in locations with heavy plaque, yet little or no lumen narrowing present before debilitating events suddenly occur. Plaque rupture can lead to artery lumen occlusion within seconds to minutes, and potential permanent debility and sometimes sudden death.</p>
<p>Plaques that have ruptured are called complicated plaques. The <a href="/wiki/Extracellular_matrix" title="Extracellular matrix">extracellular matrix</a> of the lesion breaks, usually at the shoulder of the fibrous cap that separates the lesion from the arterial lumen, where the exposed thrombogenic components of the plaque, mainly <a href="/wiki/Collagen" title="Collagen">collagen</a> will trigger <a href="/wiki/Thrombus" title="Thrombus">thrombus</a> formation. The <a href="/wiki/Thrombus" title="Thrombus">thrombus</a> then travel downstream to other blood vessels, where the blood clot may partially or completely block blood flow. If the blood flow is completely blocked, cell deaths occur due to the lack of <a href="/wiki/Oxygen" title="Oxygen">oxygen</a> supply to nearby cells, resulting in <a href="/wiki/Necrosis" title="Necrosis">necrosis</a>. The narrowing or obstruction of blood flow can occur in any artery within the body. Obstruction of arteries supplying the heart muscle result in a <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">heart attack</a>, while the obstruction of arteries supplying the brain result in a <a href="/wiki/Stroke" title="Stroke">stroke</a>.</p>
<div class="thumb tright">
<div class="thumbinner" style="width:302px;"><a href="/wiki/File:RICA_Stenosis_174302500.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/8/85/RICA_Stenosis_174302500.jpg/300px-RICA_Stenosis_174302500.jpg" width="300" height="158" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/85/RICA_Stenosis_174302500.jpg/450px-RICA_Stenosis_174302500.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/85/RICA_Stenosis_174302500.jpg/600px-RICA_Stenosis_174302500.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:RICA_Stenosis_174302500.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Doppler ultrasound of right internal Carotid artery with calcified and non-calcified plaques showing less than 70% stenosis</div>
</div>
</div>
<p>Lumen stenosis that is greater than 75% were considered as the hallmark of clinically significant disease in the past because recurring episodes of <a href="/wiki/Angina_pectoris" title="Angina pectoris">angina</a> and abnormalities in <a href="/wiki/Cardiac_stress_test" title="Cardiac stress test">stress test</a> are only detectable at that particular severity of stenosis. However, clinical trials have shown that only about 14% of clinically debilitating events occur at sites with &gt;75% stenosis. Majority of cardiovascular events that involve sudden rupture of the atheroma plaque do not display any evident narrowing of the lumen. Thus, greater attention has been focused on "vulnerable plaque" from the late 1990s onwards.<sup id="cite_ref-MaseriFuster_52-0" class="reference"><a href="#cite_note-MaseriFuster-52"><span>[</span>52<span>]</span></a></sup></p>
<p>Besides the traditional diagnostic methods such as angiography and stress-testing, other detection techniques have been developed in the past decades for earlier detection of atherosclerotic disease. Some of the detection approaches include anatomical detection and physiologic measurement.</p>
<p>Examples of anatomical detection methods include (1) coronary calcium scoring by CT, (2) carotid IMT (<a href="/wiki/Intima-media_thickness" title="Intima-media thickness">intimal media thickness</a>) measurement by ultrasound, and (3) <a href="/wiki/Intravascular_ultrasound" title="Intravascular ultrasound">intravascular ultrasound</a> (IVUS). Examples of physiologic measurement methods include (1) lipoprotein subclass analysis, (2) <a href="/wiki/Glycosylated_hemoglobin" title="Glycosylated hemoglobin" class="mw-redirect">HbA1c</a>, (3) <a href="/wiki/C-reactive_protein" title="C-reactive protein">hs-CRP</a>, and (4) <a href="/wiki/Homocysteine" title="Homocysteine">homocysteine</a>. Both anatomic and physiologic methods allow early detection before symptoms show up, disease staging and tracking of disease progression. Anatomic methods are more expensive and some of them are invasive in nature, such as IVUS. On the other hand, physiologic methods are often less expensive and safer. But they do not quantify the current state of the disease or directly track progression. In the recent years, ways of estimating the severity of atherosclerotic plaques is also made possible with the developments in nuclear imaging techniques such as PET and SPECT.</p>
<h2><span class="mw-headline" id="Prevention">Prevention</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=14" title="Edit section: Prevention">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Combinations of <a href="/wiki/Statin" title="Statin">statins</a>, <a href="/wiki/Niacin" title="Niacin">niacin</a>, intestinal cholesterol absorption-inhibiting supplements (<a href="/wiki/Ezetimibe" title="Ezetimibe">ezetimibe</a> and others, and to a much lesser extent <a href="/wiki/Fibrate" title="Fibrate">fibrates</a>) have been the most successful in changing common but sub-optimal <a href="/wiki/Lipoprotein" title="Lipoprotein">lipoprotein</a> patterns and group outcomes. In the many secondary prevention and several primary prevention trials, several classes of lipoprotein-expression-altering (less correctly termed "cholesterol-lowering") agents have consistently reduced not only heart attack, stroke and hospitalization but also all-cause mortality rates. The first of the large secondary prevention comparative statin/placebo treatment trials was the Scandinavian Simvastatin Survival Study (4S)<sup id="cite_ref-53" class="reference"><a href="#cite_note-53"><span>[</span>53<span>]</span></a></sup> with over fifteen more studies extending through to the more recent ASTEROID<sup id="cite_ref-ASTEROID_54-0" class="reference"><a href="#cite_note-ASTEROID-54"><span>[</span>54<span>]</span></a></sup> trial published in 2006. The first primary prevention comparative treatment trial was AFCAPS/TexCAPS<sup id="cite_ref-CAPS_55-0" class="reference"><a href="#cite_note-CAPS-55"><span>[</span>55<span>]</span></a></sup> with multiple later comparative statin/placebo treatment trials including EXCEL,<sup id="cite_ref-pmid1985608_56-0" class="reference"><a href="#cite_note-pmid1985608-56"><span>[</span>56<span>]</span></a></sup> ASCOT<sup id="cite_ref-pmid15855581_57-0" class="reference"><a href="#cite_note-pmid15855581-57"><span>[</span>57<span>]</span></a></sup> and SPARCL.<sup id="cite_ref-58" class="reference"><a href="#cite_note-58"><span>[</span>58<span>]</span></a></sup><sup id="cite_ref-59" class="reference"><a href="#cite_note-59"><span>[</span>59<span>]</span></a></sup> While the statin trials have all been clearly favorable for improved human outcomes, only ASTEROID and SATURN showed evidence of atherosclerotic regression (slight). Both human and animal trials that showed evidence of disease regression used more aggressive combination agent treatment strategies, which nearly always included niacin.<sup id="cite_ref-Blankenhorn_19-1" class="reference"><a href="#cite_note-Blankenhorn-19"><span>[</span>19<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=15" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Medical treatments often focus on alleviating symptoms. However measures which focus on decreasing underlying atherosclerosis—as opposed to simply treating symptoms—are more effective.<sup id="cite_ref-Fonarow.2C_G_2003_60-0" class="reference"><a href="#cite_note-Fonarow.2C_G_2003-60"><span>[</span>60<span>]</span></a></sup> Non-pharmaceutical means are usually the first method of treatment, such as stopping smoking and practicing regular exercise.<sup id="cite_ref-61" class="reference"><a href="#cite_note-61"><span>[</span>61<span>]</span></a></sup><sup id="cite_ref-62" class="reference"><a href="#cite_note-62"><span>[</span>62<span>]</span></a></sup> If these methods do not work, medicines are usually the next step in treating cardiovascular diseases, and, with improvements, have increasingly become the most effective method over the long term.</p>
<p>The key to the more effective approaches has been better understanding of the widespread and insidious nature of the disease and to combine multiple different treatment strategies, not rely on just one or a few approaches.<sup id="cite_ref-63" class="reference"><a href="#cite_note-63"><span>[</span>63<span>]</span></a></sup> In addition, for those approaches, such as lipoprotein transport behaviors, which have been shown to produce the most success, adopting more aggressive combination treatment strategies taken on a daily basis and indefinitely has generally produced better results, both before and especially after people are symptomatic.<sup id="cite_ref-Fonarow.2C_G_2003_60-1" class="reference"><a href="#cite_note-Fonarow.2C_G_2003-60"><span>[</span>60<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Statins">Statins</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=16" title="Edit section: Statins">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The group of medications referred to as <a href="/wiki/Statins" title="Statins" class="mw-redirect">statins</a> are widely prescribed for treating atherosclerosis. They shown benefit in reducing cardiovascular disease and mortality in those with <a href="/wiki/High_cholesterol" title="High cholesterol" class="mw-redirect">high cholesterol</a> with few side effects.<sup id="cite_ref-64" class="reference"><a href="#cite_note-64"><span>[</span>64<span>]</span></a></sup></p>
<p>This data is primarily in middle-age men and the conclusions are less clear for women and people over the age of 70.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65"><span>[</span>65<span>]</span></a></sup></p>
<p>Monocyte counts, as well as cholesterol markers such as LDL:HDL ratio and apolipiprotein B: apolipoprotein A-1 ratio can be used as markers to monitor the extent of atherosclerotic regression which proves useful in guiding patient treatments.<sup id="cite_ref-66" class="reference"><a href="#cite_note-66"><span>[</span>66<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Diet">Diet</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=17" title="Edit section: Diet">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Changes in diet may help prevent the development of atherosclerosis.</p>
<h3><span class="mw-headline" id="Surgery">Surgery</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=18" title="Edit section: Surgery">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Other physical treatments, include <a href="/wiki/Angioplasty" title="Angioplasty">angioplasty</a> procedures that may include <a href="/wiki/Stents" title="Stents" class="mw-redirect">stents</a> and <a href="/wiki/Coronary_artery_bypass_surgery" title="Coronary artery bypass surgery">bypass surgery</a>.</p>
<h3><span class="mw-headline" id="Other">Other</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=19" title="Edit section: Other">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>There is recent evidence that some anticoagulants, particularly warfarin, which inhibit clot formation by interfering with Vitamin K metabolism, may actually promote arterial calcification in the long term despite reducing clot formation in the short term.<sup id="cite_ref-67" class="reference"><a href="#cite_note-67"><span>[</span>67<span>]</span></a></sup><sup id="cite_ref-68" class="reference"><a href="#cite_note-68"><span>[</span>68<span>]</span></a></sup><sup id="cite_ref-69" class="reference"><a href="#cite_note-69"><span>[</span>69<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=20" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p><a href="/wiki/Dyslipidemia" title="Dyslipidemia">Lipoprotein imbalances</a>, upper normal and especially elevated blood sugar, i.e., <a href="/wiki/Diabetes" title="Diabetes" class="mw-redirect">diabetes</a> and high blood pressure are risk factors for atherosclerosis; <a href="/wiki/Homocysteine" title="Homocysteine">homocysteine</a>, stopping smoking, taking <a href="/wiki/Anticoagulant" title="Anticoagulant">anticoagulants</a> (anti-clotting agents), which target clotting factors, taking omega-3 oils from fatty fish or plant oils such as flax or canola oils, exercising and losing weight are the usual focus of treatments that have proven to be helpful in clinical trials. The target serum cholesterol level should ideally not exceed 4&#160;mmol/L (160&#160;mg/dL), and triglycerides should not exceed 2&#160;mmol/L (180&#160;mg/dL).</p>
<p>Evidence has increased that <a href="/wiki/Diabetes" title="Diabetes" class="mw-redirect">diabetics</a>, despite not having clinically detectable atherosclerotic disease, have more severe debility from atherosclerotic events over time than even non-diabetics who have already suffered atherosclerotic events. Thus <a href="/wiki/Diabetes" title="Diabetes" class="mw-redirect">diabetes</a> has been upgraded to be viewed as an advanced atherosclerotic disease equivalent<sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Please_clarify" title="Wikipedia:Please clarify"><span title="The text near this tag may need clarification or removal of jargon. (December 2010)">clarification needed</span></a></i>]</sup>.</p>
<h2><span class="mw-headline" id="Research">Research</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=21" title="Edit section: Research">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>An indication of the role of HDL on atherosclerosis has been with the rare Apo-A1 Milano human genetic variant of this HDL protein. A small short-term trial using bacterial synthetized human <a href="/wiki/ApoA-1_Milano" title="ApoA-1 Milano">Apo-A1 Milano</a> HDL in people with unstable angina produced fairly dramatic reduction in measured coronary plaque volume in only 6 weeks vs. the usual increase in plaque volume in those randomized to placebo. The trial was published in JAMA in early 2006. Ongoing work starting in the 1990s may lead to human clinical trials—probably by about 2008. These may use synthesized Apo-A1 Milano HDL directly. Or they may use gene-transfer methods to pass the ability to synthesize the Apo-A1 Milano HDLipoprotein.</p>
<p>Methods to increase <a href="/wiki/High-density_lipoprotein" title="High-density lipoprotein">high-density lipoprotein</a> (HDL) particle concentrations, which in some animal studies largely reverses and remove atheromas, are being developed and researched.</p>
<p><a href="/wiki/Niacin" title="Niacin">Niacin</a> has HDL raising effects (by 10–30%) and showed clinical trial benefit in the Coronary Drug Project and is commonly used in combination with other lipoprotein agents to improve efficacy of changing lipoprotein for the better. However most individuals have nuisance symptoms with short term flushing reactions, especially initially, and so working with a physician with a history of successful experience with niacin implementation, careful selection of brand, dosing strategy, etc. are usually critical to success.</p>
<p>However, increasing HDL by any means is not necessarily helpful. For example, the drug <a href="/wiki/Torcetrapib" title="Torcetrapib">torcetrapib</a> is the most effective agent currently known for raising HDL (by up to 60%). However, in clinical trials it also raised deaths by 60%. All studies regarding this drug were halted in December 2006.<sup id="cite_ref-70" class="reference"><a href="#cite_note-70"><span>[</span>70<span>]</span></a></sup> See <a href="/wiki/CETP_inhibitor" title="CETP inhibitor">CETP inhibitor</a> for similar approaches.</p>
<p>The actions of macrophages drive atherosclerotic plaque progression. <i>Immunomodulation of atherosclerosis</i> is the term for techniques that modulate immune system function to suppress this macrophage action.<sup id="cite_ref-Nilsson_71-0" class="reference"><a href="#cite_note-Nilsson-71"><span>[</span>71<span>]</span></a></sup></p>
<p>Research on genetic expression and control mechanisms is progressing. Topics include</p>
<ul>
<li><a href="/wiki/Peroxisome_proliferator-activated_receptors" title="Peroxisome proliferator-activated receptors" class="mw-redirect">PPAR</a>, known to be important in blood sugar and variants of lipoprotein production and function;</li>
<li>The multiple variants of the proteins that form the lipoprotein transport particles.</li>
</ul>
<p>Some controversial research has suggested a link between atherosclerosis and the presence of several different <a href="/wiki/Nanobacterium" title="Nanobacterium">nanobacteria</a> in the arteries, e.g., <a href="/wiki/Chlamydophila_pneumoniae" title="Chlamydophila pneumoniae">Chlamydophila pneumoniae</a>, though trials of current antibiotic treatments known to be usually effective in suppressing growth or killing these bacteria have not been successful in improving outcomes.<sup id="cite_ref-72" class="reference"><a href="#cite_note-72"><span>[</span>72<span>]</span></a></sup></p>
<p>The immunomodulation approaches mentioned above, because they deal with innate responses of the host to promote atherosclerosis, have far greater prospects for success.</p>
<h3><span class="mw-headline" id="miRNA">miRNA</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=22" title="Edit section: miRNA">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>miRNAs have complementary sequences in the 3’ utr and 5’ utr of target mRNAs of protein-coding genes, and cause mRNA cleavage or repression of translational machinery. In diseased vacular vessels, miRNAs are dysregulated and highly expressed. miR-33 is found in cardiovascular diseases.<sup id="cite_ref-ReferenceA_73-0" class="reference"><a href="#cite_note-ReferenceA-73"><span>[</span>73<span>]</span></a></sup> It is involved in atherosclerotic initiation and pregression including lipid metabolism, insulin signaling and glucose homeostatis, cell type progression and proliferation, and myeloid cell differentialtion. It was found in rodant that the inhibition of miR-33 will raise HDL level and the expression of miR-33 is down regulated in human with atherosclerotic plaques.<sup id="cite_ref-74" class="reference"><a href="#cite_note-74"><span>[</span>74<span>]</span></a></sup><sup id="cite_ref-75" class="reference"><a href="#cite_note-75"><span>[</span>75<span>]</span></a></sup><sup id="cite_ref-76" class="reference"><a href="#cite_note-76"><span>[</span>76<span>]</span></a></sup><sup id="cite_ref-77" class="reference"><a href="#cite_note-77"><span>[</span>77<span>]</span></a></sup></p>
<p>miR-33a and miR-33b are located on intron 16 of human sterol regulatory element-binding protein 2 (SREBP2) gene on chromosome 22 and intron 17 of SREBP1 gene on chromosome 17.<sup id="cite_ref-78" class="reference"><a href="#cite_note-78"><span>[</span>78<span>]</span></a></sup> miR-33a/b regulates cholesterol/lipid homeostatis by binding in the 3’UTRs of genes involved in cholesterol transport such as ATP binding Cassette (ABC) transporters and enhance or represses its expression. Study have shown that ABCA1 mediates transport of cholesterol from peripheral tissues to Apolupoprotein-1 and it is also important in the reverse cholesterol transport pathway, where cholesterol is deliverd from peripheral tissue to the liver, where it can be excreted into bile or converted to bile acids prior to excretion.<sup id="cite_ref-ReferenceA_73-1" class="reference"><a href="#cite_note-ReferenceA-73"><span>[</span>73<span>]</span></a></sup> Therefore, we know that ABCA1 plays an important role in preventing cholesterol accumulation in macrophages. By enhancing miR-33 function, the level of ABCA1 is decreased, leading to decrease cellular cholesterol efflux to apoA-1. On the other hand, by inhibiting miR-33 function, the level of ABCA1 is increased and increases the cholesterol efflux to apoA-1. Suppression of miR-33 will lead to less cellular cholesterol and higher plasma HDL level through the regulation of ABCA1 expression.<sup id="cite_ref-79" class="reference"><a href="#cite_note-79"><span>[</span>79<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Economics">Economics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=23" title="Edit section: Economics">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>In 2011, coronary athersclerosis was one of the top ten most expensive conditions seen during inpatient hospitalizations in the U.S., with aggregate inpatient hospital costs of $10.4 billion.<sup id="cite_ref-80" class="reference"><a href="#cite_note-80"><span>[</span>80<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=24" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a href="/wiki/Angiogram" title="Angiogram" class="mw-redirect">Angiogram</a></li>
<li><a href="/wiki/Arterial_stiffness" title="Arterial stiffness">Arterial stiffness</a></li>
<li><a href="/wiki/Arteriosclerosis" title="Arteriosclerosis">Arteriosclerosis</a></li>
<li><a href="/wiki/Atheroma" title="Atheroma">Atheroma</a></li>
<li><a href="/wiki/Chelation_therapy" title="Chelation therapy">Chelation therapy</a></li>
<li><a href="/wiki/Coronary_catheterization" title="Coronary catheterization">Coronary catheterization</a></li>
<li><a href="/wiki/Coronary_circulation" title="Coronary circulation">Coronary circulation</a></li>
<li><a href="/wiki/Fatty_streaks" title="Fatty streaks" class="mw-redirect">Fatty streaks</a></li>
<li><a href="/wiki/Intravascular_ultrasound" title="Intravascular ultrasound">Intravascular ultrasound</a></li>
<li><a href="/wiki/Monckeberg%27s_arteriosclerosis" title="Monckeberg's arteriosclerosis">Monckeberg's arteriosclerosis</a></li>
</ul>
<h2><span class="mw-headline" id="Footnotes">Footnotes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=25" title="Edit section: Footnotes">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-1">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.mercksource.com">http://www.mercksource.com</a></span></li>
<li id="cite_note-:0-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-:0_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:0_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:0_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-:0_2-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Maton, Anthea; Roshan L. Jean Hopkins, Charles William McLaughlin, Susan Johnson, Maryanna Quon Warner, David LaHart, Jill D. Wright (1993). <i>Human Biology and Health</i>. Englewood Cliffs, NJ: Prentice Hall. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-13-981176-1" title="Special:BookSources/0-13-981176-1">0-13-981176-1</a>. <a href="/wiki/OCLC" title="OCLC">OCLC</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/oclc/32308337">32308337</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.aufirst=Anthea&amp;rft.aulast=Maton&amp;rft.au=Maton%2C+Anthea&amp;rft.btitle=Human+Biology+and+Health&amp;rft.date=1993&amp;rft.genre=book&amp;rft_id=info%3Aoclcnum%2F32308337&amp;rft.isbn=0-13-981176-1&amp;rft.place=Englewood+Cliffs%2C+NJ&amp;rft.pub=Prentice+Hall&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-:1-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-:1_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:1_3-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Ross R (April 1993). "The pathogenesis of atherosclerosis: a perspective for the 1990s". <i>Nature</i> <b>362</b> (6423): 801–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1038%2F362801a0">10.1038/362801a0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8479518">8479518</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=The+pathogenesis+of+atherosclerosis%3A+a+perspective+for+the+1990s&amp;rft.aulast=Ross+R&amp;rft.au=Ross+R&amp;rft.date=April+1993&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2F362801a0&amp;rft_id=info%3Apmid%2F8479518&amp;rft.issue=6423&amp;rft.jtitle=Nature&amp;rft.pages=801%E2%80%939&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=362" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><span class="citation journal">Ross R; Ross, Russell (January 1999). "Atherosclerosis — An Inflammatory Disease". <i>New England Journal of Medicine</i> <b>340</b> (2): 115–26. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1056%2FNEJM199901143400207">10.1056/NEJM199901143400207</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9887164">9887164</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Atherosclerosis+%E2%80%94+An+Inflammatory+Disease&amp;rft.aulast=Ross+R&amp;rft.au=Ross%2C+Russell&amp;rft.au=Ross+R&amp;rft.date=January+1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM199901143400207&amp;rft_id=info%3Apmid%2F9887164&amp;rft.issue=2&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.pages=115%E2%80%9326&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=340" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><span class="citation journal">Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R (July 2010). <a rel="nofollow" class="external text" href="http://atvb.ahajournals.org/cgi/pmidlookup?view=long&amp;pmid=20554950">"Concept of vulnerable/unstable plaque"</a>. <i>Arterioscler. Thromb. Vasc. Biol.</i> <b>30</b> (7): 1282–92. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1161%2FATVBAHA.108.179739">10.1161/ATVBAHA.108.179739</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20554950">20554950</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Concept+of+vulnerable%2Funstable+plaque&amp;rft.au=Finn+AV%2C+Nakano+M%2C+Narula+J%2C+Kolodgie+FD%2C+Virmani+R&amp;rft.aulast=Finn+AV%2C+Nakano+M%2C+Narula+J%2C+Kolodgie+FD%2C+Virmani+R&amp;rft.date=July+2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fatvb.ahajournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D20554950&amp;rft_id=info%3Adoi%2F10.1161%2FATVBAHA.108.179739&amp;rft_id=info%3Apmid%2F20554950&amp;rft.issue=7&amp;rft.jtitle=Arterioscler.+Thromb.+Vasc.+Biol.&amp;rft.pages=1282%E2%80%9392&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><span class="citation journal">Didangelos A, Simper D, Monaco C, Mayr M (May 2009). <a rel="nofollow" class="external text" href="http://www.springerlink.com/content/8qjl665766630k8p/fulltext.pdf">"Proteomics of acute coronary syndromes."</a>. <i>Current atherosclerosis reports</i> <b>11</b> (3): 188–95. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2Fs11883-009-0030-x">10.1007/s11883-009-0030-x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19361350">19361350</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Proteomics+of+acute+coronary+syndromes.&amp;rft.au=Didangelos+A%2C+Simper+D%2C+Monaco+C%2C+Mayr+M&amp;rft.aulast=Didangelos+A%2C+Simper+D%2C+Monaco+C%2C+Mayr+M&amp;rft.date=May+2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8qjl665766630k8p%2Ffulltext.pdf&amp;rft_id=info%3Adoi%2F10.1007%2Fs11883-009-0030-x&amp;rft_id=info%3Apmid%2F19361350&amp;rft.issue=3&amp;rft.jtitle=Current+atherosclerosis+reports&amp;rft.pages=188%E2%80%9395&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text">Atherosclerosis. Harvard Health Publications Harvard Health Publications. Health Topics A – Z, <a rel="nofollow" class="external free" href="http://myaccess.library.utoronto.ca/login?url=http://search.proquest.com.myaccess.library.utoronto.ca/docview/1370739792?accountid=14771">http://myaccess.library.utoronto.ca/login?url=http://search.proquest.com.myaccess.library.utoronto.ca/docview/1370739792?accountid=14771</a> (2011)</span></li>
<li id="cite_note-nhlbi.nih.gov-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-nhlbi.nih.gov_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-nhlbi.nih.gov_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-nhlbi.nih.gov_8-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text">Atherosclerosis. National Heart, Lung and Blood Institute. <a rel="nofollow" class="external free" href="http://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis/signs.html">http://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis/signs.html</a> (2011)</span></li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.news-medical.net/news/20120201/First-signs-of-atherosclerotic-heart-disease-may-appear-in-early-childhood.aspx">http://www.news-medical.net/news/20120201/First-signs-of-atherosclerotic-heart-disease-may-appear-in-early-childhood.aspx</a> Retrieved Feb-27-13</span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text">Flora, G., Baker, A.B., Loewenson, R.B., and Klassen, A. C. A Comparative Study of Cerebral Atherosclerosis in Males and Females. <i>Circulation</i> 38, 859-869 <a rel="nofollow" class="external free" href="http://circ.ahajournals.org/content/38/5/859.full.pdf">http://circ.ahajournals.org/content/38/5/859.full.pdf</a> (1968)</span></li>
<li id="cite_note-heartandstroke.com-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-heartandstroke.com_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-heartandstroke.com_11-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Arrhythmia. Heart and Stroke Foundation. <a rel="nofollow" class="external free" href="http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.3484057/">http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.3484057/</a> (2011)</span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text">Sims, N.R. and Muderman, H. Mitochondria, oxidative metabolism and cell death in stroke. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1802, 80-91 <a rel="nofollow" class="external free" href="http://www.sciencedirect.com/science/article/pii/S0925443909002142">http://www.sciencedirect.com/science/article/pii/S0925443909002142</a> (2010)</span></li>
<li id="cite_note-Enos-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-Enos_13-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Enos WF, Holmes RH, Beyer J (1953). "Coronary disease among United States soldiers killed in action in Korea: Preliminary Report". <i>JAMA</i> <b>152</b> (12): 1090–93.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Coronary+disease+among+United+States+soldiers+killed+in+action+in+Korea%3A+Preliminary+Report&amp;rft.au=Enos+WF%2C+Holmes+RH%2C+Beyer+J&amp;rft.aulast=Enos+WF%2C+Holmes+RH%2C+Beyer+J&amp;rft.date=1953&amp;rft.genre=article&amp;rft.issue=12&amp;rft.jtitle=JAMA&amp;rft.pages=1090%E2%80%9393&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=152" class="Z3988"><span style="display:none;">&#160;</span></span> The average age was calculated from the ages of 200 of the soldiers. No age was recorded in nearly 100 of the men.</span></li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><span class="citation journal">Williams, KJ; Tabas, I (May 1995). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2924812">"The Response-to-Retention Hypothesis of Early Atherogenesis"</a>. <i>Arteriosclerosis, thrombosis, and vascular biology</i> <b>15</b> (5): 551–61. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1161%2F01.ATV.15.5.551">10.1161/01.ATV.15.5.551</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2924812">2924812</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7749869">7749869</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=The+Response-to-Retention+Hypothesis+of+Early+Atherogenesis&amp;rft.aufirst=KJ&amp;rft.aulast=Williams&amp;rft.au=Williams%2C+KJ&amp;rft.date=May+1995&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2924812&amp;rft_id=info%3Adoi%2F10.1161%2F01.ATV.15.5.551&amp;rft_id=info%3Apmc%2F2924812&amp;rft_id=info%3Apmid%2F7749869&amp;rft.issue=5&amp;rft.jtitle=Arteriosclerosis%2C+thrombosis%2C+and+vascular+biology&amp;rft.pages=551%E2%80%9361&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation journal">Sparrow, CP; Olszewski, J (July 1993). "Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions". <i>Journal of lipid research</i> <b>34</b> (7): 1219–28. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8103788">8103788</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Cellular+oxidation+of+low+density+lipoprotein+is+caused+by+thiol+production+in+media+containing+transition+metal+ions&amp;rft.aufirst=CP&amp;rft.aulast=Sparrow&amp;rft.au=Sparrow%2C+CP&amp;rft.date=July+1993&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F8103788&amp;rft.issue=7&amp;rft.jtitle=Journal+of+lipid+research&amp;rft.pages=1219%E2%80%9328&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=34" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><span class="citation journal">Fabricant CG, Fabricant J (1999). "Atherosclerosis induced by infection with Marek's disease herpesvirus in chickens". <i>Am Heart J</i> <b>138</b> (5 Pt 2): S465–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0002-8703%2899%2970276-0">10.1016/S0002-8703(99)70276-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10539849">10539849</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Atherosclerosis+induced+by+infection+with+Marek%27s+disease+herpesvirus+in+chickens&amp;rft.au=Fabricant+CG%2C+Fabricant+J&amp;rft.aulast=Fabricant+CG%2C+Fabricant+J&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0002-8703%2899%2970276-0&amp;rft_id=info%3Apmid%2F10539849&amp;rft.issue=5+Pt+2&amp;rft.jtitle=Am+Heart+J&amp;rft.pages=S465%E2%80%938&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=138" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><span class="citation journal">Hsu HY, Nicholson AC, Pomerantz KB, Kaner RJ, Hajjar DP (August 1995). <a rel="nofollow" class="external text" href="http://www.jbc.org/cgi/pmidlookup?view=long&amp;pmid=7642651">"Altered cholesterol trafficking in herpesvirus-infected arterial cells. Evidence for viral protein kinase-mediated cholesterol accumulation"</a>. <i>J Biol Chem</i> <b>270</b> (33): 19630–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1074%2Fjbc.270.33.19630">10.1074/jbc.270.33.19630</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7642651">7642651</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Altered+cholesterol+trafficking+in+herpesvirus-infected+arterial+cells.+Evidence+for+viral+protein+kinase-mediated+cholesterol+accumulation&amp;rft.au=Hsu+HY%2C+Nicholson+AC%2C+Pomerantz+KB%2C+Kaner+RJ%2C+Hajjar+DP&amp;rft.aulast=Hsu+HY%2C+Nicholson+AC%2C+Pomerantz+KB%2C+Kaner+RJ%2C+Hajjar+DP&amp;rft.date=August+1995&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.jbc.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D7642651&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.270.33.19630&amp;rft_id=info%3Apmid%2F7642651&amp;rft.issue=33&amp;rft.jtitle=J+Biol+Chem&amp;rft.pages=19630%E2%80%937&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=270" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation journal">Cheng J, Ke Q, Jin Z, Wang H, Kocher O, Morgan JP, Zhang J, Crumpacker CS (May 2009). <a rel="nofollow" class="external text" href="http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1000427">"Cytomegalovirus Infection Causes an Increase of Arterial Blood Pressure"</a>. In Früh, Klaus. <i>PLoS Pathog</i> <b>5</b> (5): e1000427. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1371%2Fjournal.ppat.1000427">10.1371/journal.ppat.1000427</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2673691">2673691</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19436702">19436702</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Cytomegalovirus+Infection+Causes+an+Increase+of+Arterial+Blood+Pressure&amp;rft.au=Cheng+J%2C++Ke+Q%2C++Jin+Z%2C++Wang+H%2C++Kocher+O%2C+Morgan+JP%2C+Zhang+J%2C+Crumpacker+CS&amp;rft.aulast=Cheng+J%2C++Ke+Q%2C++Jin+Z%2C++Wang+H%2C++Kocher+O%2C+Morgan+JP%2C+Zhang+J%2C+Crumpacker+CS&amp;rft.date=May+2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.plospathogens.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.ppat.1000427&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.ppat.1000427&amp;rft_id=info%3Apmc%2F2673691&amp;rft_id=info%3Apmid%2F19436702&amp;rft.issue=5&amp;rft.jtitle=PLoS+Pathog&amp;rft.pages=e1000427&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Blankenhorn-19"><span class="mw-cite-backlink">^ <a href="#cite_ref-Blankenhorn_19-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Blankenhorn_19-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Blankenhorn DH, Hodis HN (August 1993). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1022223">"Atherosclerosis--reversal with therapy"</a>. <i>The Western journal of medicine</i> <b>159</b> (2): 172–9. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1022223">1022223</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8212682">8212682</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Atherosclerosis--reversal+with+therapy&amp;rft.au=Blankenhorn+DH%2C+Hodis+HN&amp;rft.aulast=Blankenhorn+DH%2C+Hodis+HN&amp;rft.date=August+1993&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1022223&amp;rft_id=info%3Apmc%2F1022223&amp;rft_id=info%3Apmid%2F8212682&amp;rft.issue=2&amp;rft.jtitle=The+Western+journal+of+medicine&amp;rft.pages=172%E2%80%939&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=159" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Kumar345-20"><span class="mw-cite-backlink">^ <a href="#cite_ref-Kumar345_20-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kumar345_20-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Kumar345_20-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Kumar345_20-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Kumar345_20-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Kumar345_20-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Kumar345_20-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Kumar345_20-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Kumar345_20-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Kumar345_20-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Kumar345_20-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Kumar345_20-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Kumar345_20-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Kumar345_20-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Kumar345_20-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Kumar345_20-15"><sup><i><b>p</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson (2007). <i>Robbins Basic Pathology: With STUDENT CONSULT Online Access</i> (8th ed.). Philadelphia: Saunders. p.&#160;345. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-4160-2973-7" title="Special:BookSources/1-4160-2973-7">1-4160-2973-7</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.aulast=Mitchell%2C+Richard+Sheppard%3B+Kumar%2C+Vinay%3B+Abbas%2C+Abul+K.%3B+Fausto%2C+Nelson&amp;rft.au=Mitchell%2C+Richard+Sheppard%3B+Kumar%2C+Vinay%3B+Abbas%2C+Abul+K.%3B+Fausto%2C+Nelson&amp;rft.btitle=Robbins+Basic+Pathology%3A+With+STUDENT+CONSULT+Online+Access&amp;rft.date=2007&amp;rft.edition=8th&amp;rft.genre=book&amp;rft.isbn=1-4160-2973-7&amp;rft.pages=345&amp;rft.place=Philadelphia&amp;rft.pub=Saunders&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><span class="citation journal">Narain VS, Gupta N, Sethi R, <i>et al.</i> (2008). "Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome". <i>Indian Heart J</i> <b>60</b> (6): 536–42. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19276492">19276492</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Clinical+correlation+of+multiple+biomarkers+for+risk+assessment+in+patients+with+acute+coronary+syndrome&amp;rft.aulast=Narain+VS%2C+Gupta+N%2C+Sethi+R%2C+%27%27et+al.%27%27&amp;rft.au=Narain+VS%2C+Gupta+N%2C+Sethi+R%2C+%27%27et+al.%27%27&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F19276492&amp;rft.issue=6&amp;rft.jtitle=Indian+Heart+J&amp;rft.pages=536%E2%80%9342&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=60" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><span class="citation journal">Rinehart JF, Greenberg LD (May 1949). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1942913">"Arteriosclerotic Lesions in Pyridoxine-Deficient Monkeys"</a>. <i>Am. J. Pathol.</i> <b>25</b> (3): 481–91. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1942913">1942913</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18127137">18127137</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Arteriosclerotic+Lesions+in+Pyridoxine-Deficient+Monkeys&amp;rft.aulast=Rinehart+JF%2C+Greenberg+LD&amp;rft.au=Rinehart+JF%2C+Greenberg+LD&amp;rft.date=May+1949&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1942913&amp;rft_id=info%3Apmc%2F1942913&amp;rft_id=info%3Apmid%2F18127137&amp;rft.issue=3&amp;rft.jtitle=Am.+J.+Pathol.&amp;rft.pages=481%E2%80%9391&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=25" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><span class="citation journal">Rinehart JF, Greenberg LD (1956). <a rel="nofollow" class="external text" href="http://www.ajcn.org/cgi/pmidlookup?view=long&amp;pmid=13339702">"Vitamin B<sub>6</sub> deficiency in the rhesus monkey; with particular reference to the occurrence of atherosclerosis, dental caries, and hepatic cirrhosis"</a>. <i>Am. J. Clin. Nutr.</i> <b>4</b> (4): 318–25; discussion, 325–8. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/13339702">13339702</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Vitamin+B%3Csub%3E6%3C%2Fsub%3E+deficiency+in+the+rhesus+monkey%3B+with+particular+reference+to+the+occurrence+of+atherosclerosis%2C+dental+caries%2C+and+hepatic+cirrhosis&amp;rft.aulast=Rinehart+JF%2C+Greenberg+LD&amp;rft.au=Rinehart+JF%2C+Greenberg+LD&amp;rft.date=1956&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.ajcn.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D13339702&amp;rft_id=info%3Apmid%2F13339702&amp;rft.issue=4&amp;rft.jtitle=Am.+J.+Clin.+Nutr.&amp;rft.pages=318%E2%80%9325%3B+discussion%2C+325%E2%80%938&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><span class="citation book">Gruberg, E.R., Raymond, S.A. (1981). <i>Beyond Cholesterol: Vitamin B<sub>6</sub>, Arteriosclerosis, and Your Heart</i> (1st ed.). New York: St. Martin's Press.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.au=Gruberg%2C+E.R.%2C+Raymond%2C+S.A.&amp;rft.aulast=Gruberg%2C+E.R.%2C+Raymond%2C+S.A.&amp;rft.btitle=Beyond+Cholesterol%3A+Vitamin+B%3Csub%3E6%3C%2Fsub%3E%2C+Arteriosclerosis%2C+and+Your+Heart&amp;rft.date=1981&amp;rft.edition=1st&amp;rft.genre=book&amp;rft.place=New+York&amp;rft.pub=St.+Martin%27s+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Kocher_T_1883_254.E2.80.93337-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kocher_T_1883_254.E2.80.93337_25-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Kocher T (1883). "Uber Kropf exstirpation und ihre Folgen". <i>Arch Klin Chir</i> <b>29</b>: 254–337.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Uber+Kropf+exstirpation+und+ihre+Folgen&amp;rft.au=Kocher+T&amp;rft.aulast=Kocher+T&amp;rft.date=1883&amp;rft.genre=article&amp;rft.jtitle=Arch+Klin+Chir&amp;rft.pages=254%E2%80%93337&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=29" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Turner_KB_1933_115.E2.80.93125-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-Turner_KB_1933_115.E2.80.93125_26-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Turner KB (1933). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2132282">"Studies on the prevention of cholesterol atherosclerosis in rabbits"</a>. <i>J Exp Med</i> <b>58</b> (1): 115–125. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1084%2Fjem.58.1.115">10.1084/jem.58.1.115</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2132282">2132282</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19870177">19870177</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Studies+on+the+prevention+of+cholesterol+atherosclerosis+in+rabbits&amp;rft.aulast=Turner+KB&amp;rft.au=Turner+KB&amp;rft.date=1933&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2132282&amp;rft_id=info%3Adoi%2F10.1084%2Fjem.58.1.115&amp;rft_id=info%3Apmc%2F2132282&amp;rft_id=info%3Apmid%2F19870177&amp;rft.issue=1&amp;rft.jtitle=J+Exp+Med&amp;rft.pages=115%E2%80%93125&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=58" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Katamine_S.2C_Hoshino_N.2C_Totsuka_K.2C_Suzuki_M._1985_339.E2.80.93345-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-Katamine_S.2C_Hoshino_N.2C_Totsuka_K.2C_Suzuki_M._1985_339.E2.80.93345_27-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Katamine S, Hoshino N, Totsuka K, Suzuki M. (1985). "Effects of the longterm feeding of high-iodine eggs on lipid metabolism and thyroid function in rats". <i>J Nutr Sci Vitaminol</i> <b>31</b> (3): 339–345. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.3177%2Fjnsv.31.339">10.3177/jnsv.31.339</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Effects+of+the+longterm+feeding+of+high-iodine+eggs+on+lipid+metabolism+and+thyroid+function+in+rats&amp;rft.au=Katamine+S%2C++Hoshino+N%2C+Totsuka+K%2C+Suzuki+M.&amp;rft.aulast=Katamine+S%2C++Hoshino+N%2C+Totsuka+K%2C+Suzuki+M.&amp;rft.date=1985&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3177%2Fjnsv.31.339&amp;rft.issue=3&amp;rft.jtitle=J+Nutr+Sci+Vitaminol&amp;rft.pages=339%E2%80%93345&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Cann_SA_2006_1.E2.80.9311-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-Cann_SA_2006_1.E2.80.9311_28-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Cann SA (2006). "Hypothesis: dietary iodine intake in the etiology of cardiovascular disease". <i>J Am Coll Nutr-volume=25</i>: 1–11.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Hypothesis%3A+dietary+iodine+intake+in+the+etiology+of+cardiovascular+disease&amp;rft.au=Cann+SA&amp;rft.aulast=Cann+SA&amp;rft.date=2006&amp;rft.genre=article&amp;rft.jtitle=J+Am+Coll+Nutr-volume%3D25&amp;rft.pages=1%E2%80%9311&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Venturi.2C_Sebastiano_2011_155.E2.80.93162-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-Venturi.2C_Sebastiano_2011_155.E2.80.93162_29-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Venturi, Sebastiano (2011). "Evolutionary Significance of Iodine". <i>Current Chemical Biology-</i> <b>5</b> (3): 155–162. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2174%2F187231311796765012">10.2174/187231311796765012</a>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1872-3136">1872-3136</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Evolutionary+Significance+of+Iodine&amp;rft.aulast=Venturi%2C+Sebastiano&amp;rft.au=Venturi%2C+Sebastiano&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2174%2F187231311796765012&amp;rft.issn=1872-3136&amp;rft.issue=3&amp;rft.jtitle=Current+Chemical+Biology-&amp;rft.pages=155%E2%80%93162&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><span class="citation journal">Borissoff JI, Spronk HM, Heeneman S, ten Cate H (June 2009). <a rel="nofollow" class="external text" href="http://cardiovascres.oxfordjournals.org/content/82/3/392.long">"Is thrombin a key player in the 'coagulation-atherogenesis' maze?"</a>. <i>Cardiovasc. Res.</i> <b>82</b> (3): 392–403. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1093%2Fcvr%2Fcvp066">10.1093/cvr/cvp066</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19228706">19228706</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Is+thrombin+a+key+player+in+the+%27coagulation-atherogenesis%27+maze%3F&amp;rft.au=Borissoff+JI%2C+Spronk+HM%2C+Heeneman+S%2C+ten+Cate+H&amp;rft.aulast=Borissoff+JI%2C+Spronk+HM%2C+Heeneman+S%2C+ten+Cate+H&amp;rft.date=June+2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcardiovascres.oxfordjournals.org%2Fcontent%2F82%2F3%2F392.long&amp;rft_id=info%3Adoi%2F10.1093%2Fcvr%2Fcvp066&amp;rft_id=info%3Apmid%2F19228706&amp;rft.issue=3&amp;rft.jtitle=Cardiovasc.+Res.&amp;rft.pages=392%E2%80%93403&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=82" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><span class="citation journal">Borissoff JI, Heeneman S, Kilinç E, <i>et al.</i> (August 2010). <a rel="nofollow" class="external text" href="http://circ.ahajournals.org/cgi/content/full/122/8/821">"Early atherosclerosis exhibits an enhanced procoagulant state"</a>. <i>Circulation</i> <b>122</b> (8): 821–30. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1161%2FCIRCULATIONAHA.109.907121">10.1161/CIRCULATIONAHA.109.907121</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20697022">20697022</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Early+atherosclerosis+exhibits+an+enhanced+procoagulant+state&amp;rft.au=Borissoff+JI%2C+Heeneman+S%2C+Kilin%C3%A7+E%2C+%27%27et+al.%27%27&amp;rft.aulast=Borissoff+JI%2C+Heeneman+S%2C+Kilin%C3%A7+E%2C+%27%27et+al.%27%27&amp;rft.date=August+2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcirc.ahajournals.org%2Fcgi%2Fcontent%2Ffull%2F122%2F8%2F821&amp;rft_id=info%3Adoi%2F10.1161%2FCIRCULATIONAHA.109.907121&amp;rft_id=info%3Apmid%2F20697022&amp;rft.issue=8&amp;rft.jtitle=Circulation&amp;rft.pages=821%E2%80%9330&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=122" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><span class="citation journal">Borissoff JI, Spronk HM, ten Cate H (May 2011). <a rel="nofollow" class="external text" href="http://www.nejm.org/doi/abs/10.1056/NEJMra1011670">"The hemostatic system as a modulator of atherosclerosis"</a>. <i>N. Engl. J. Med.</i> <b>364</b> (18): 1746–60. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1056%2FNEJMra1011670">10.1056/NEJMra1011670</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21542745">21542745</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=The+hemostatic+system+as+a+modulator+of+atherosclerosis&amp;rft.au=Borissoff+JI%2C+Spronk+HM%2C+ten+Cate+H&amp;rft.aulast=Borissoff+JI%2C+Spronk+HM%2C+ten+Cate+H&amp;rft.date=May+2011&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nejm.org%2Fdoi%2Fabs%2F10.1056%2FNEJMra1011670&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMra1011670&amp;rft_id=info%3Apmid%2F21542745&amp;rft.issue=18&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1746%E2%80%9360&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=364" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><span class="citation book">Food and nutrition board, institute of medicine of the national academies (2005). <a rel="nofollow" class="external text" href="http://www.nap.edu/openbook.php?record_id=10490&amp;page=481"><i>Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients)</i></a>. National Academies Press. pp.&#160;481–484.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.au=Food+and+nutrition+board%2C+institute+of+medicine+of+the+national+academies&amp;rft.aulast=Food+and+nutrition+board%2C+institute+of+medicine+of+the+national+academies&amp;rft.btitle=Dietary+Reference+Intakes+for+Energy%2C+Carbohydrate%2C+Fiber%2C+Fat%2C+Fatty+Acids%2C+Cholesterol%2C+Protein%2C+and+Amino+Acids+%28Macronutrients%29&amp;rft.date=2005&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.nap.edu%2Fopenbook.php%3Frecord_id%3D10490%26page%3D481&amp;rft.pages=481%E2%80%93484&amp;rft.pub=National+Academies+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><span class="citation book">Food and nutrition board, institute of medicine of the national academies (2005). <a rel="nofollow" class="external text" href="http://www.nap.edu/openbook.php?record_id=10490&amp;page=494"><i>Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients)</i></a>. National Academies Press. pp.&#160;494–505.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.au=Food+and+nutrition+board%2C+institute+of+medicine+of+the+national+academies&amp;rft.aulast=Food+and+nutrition+board%2C+institute+of+medicine+of+the+national+academies&amp;rft.btitle=Dietary+Reference+Intakes+for+Energy%2C+Carbohydrate%2C+Fiber%2C+Fat%2C+Fatty+Acids%2C+Cholesterol%2C+Protein%2C+and+Amino+Acids+%28Macronutrients%29&amp;rft.date=2005&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.nap.edu%2Fopenbook.php%3Frecord_id%3D10490%26page%3D494&amp;rft.pages=494%E2%80%93505&amp;rft.pub=National+Academies+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Bhatt-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-Bhatt_35-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Bhatt DL, Topol EJ (July 2002). <a rel="nofollow" class="external text" href="http://circ.ahajournals.org/cgi/content/full/circulationaha;106/1/136">"Need to test the arterial inflammation hypothesis"</a>. <i>Circulation</i> <b>106</b> (1): 136–40. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1161%2F01.CIR.0000021112.29409.A2">10.1161/01.CIR.0000021112.29409.A2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12093783">12093783</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Need+to+test+the+arterial+inflammation+hypothesis&amp;rft.au=Bhatt+DL%2C+Topol+EJ&amp;rft.aulast=Bhatt+DL%2C+Topol+EJ&amp;rft.date=July+2002&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcirc.ahajournals.org%2Fcgi%2Fcontent%2Ffull%2Fcirculationaha%3B106%2F1%2F136&amp;rft_id=info%3Adoi%2F10.1161%2F01.CIR.0000021112.29409.A2&amp;rft_id=info%3Apmid%2F12093783&amp;rft.issue=1&amp;rft.jtitle=Circulation&amp;rft.pages=136%E2%80%9340&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=106" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Hyperinsulinaemia-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-Hyperinsulinaemia_36-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Griffin M, Frazer A, Johnson A, Collins P, Owens D, Tomkin GH (1998). "Cellular cholesterol synthesis—the relationship to post-prandial glucose and insulin following weight loss". <i>Atherosclerosis.</i> <b>138</b> (2): 313–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0021-9150%2898%2900036-7">10.1016/S0021-9150(98)00036-7</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9690914">9690914</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Cellular+cholesterol+synthesis%E2%80%94the+relationship+to+post-prandial+glucose+and+insulin+following+weight+loss&amp;rft.au=Griffin+M%2C+Frazer+A%2C+Johnson+A%2C+Collins+P%2C+Owens+D%2C+Tomkin+GH&amp;rft.aulast=Griffin+M%2C+Frazer+A%2C+Johnson+A%2C+Collins+P%2C+Owens+D%2C+Tomkin+GH&amp;rft.date=1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0021-9150%2898%2900036-7&amp;rft_id=info%3Apmid%2F9690914&amp;rft.issue=2&amp;rft.jtitle=Atherosclerosis.&amp;rft.pages=313%E2%80%938&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=138" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><span class="citation journal">King, Cr; Knutson, Kl; Rathouz, Pj; Sidney, S; Liu, K; Lauderdale, Ds (December 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2661105">"Short sleep duration and incident coronary artery calcification"</a>. <i>JAMA: the Journal of the American Medical Association</i> <b>300</b> (24): 2859–66. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1001%2Fjama.2008.867">10.1001/jama.2008.867</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2661105">2661105</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19109114">19109114</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Short+sleep+duration+and+incident+coronary+artery+calcification&amp;rft.au=King%2C+Cr%3B+Knutson%2C+Kl%3B+Rathouz%2C+Pj%3B+Sidney%2C+S%3B+Liu%2C+K%3B+Lauderdale%2C+Ds&amp;rft.aulast=King%2C+Cr%3B+Knutson%2C+Kl%3B+Rathouz%2C+Pj%3B+Sidney%2C+S%3B+Liu%2C+K%3B+Lauderdale%2C+Ds&amp;rft.date=December+2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2661105&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2008.867&amp;rft_id=info%3Apmc%2F2661105&amp;rft_id=info%3Apmid%2F19109114&amp;rft.issue=24&amp;rft.jtitle=JAMA%3A+the+Journal+of+the+American+Medical+Association&amp;rft.pages=2859%E2%80%9366&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=300" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-PLoSMed42313-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-PLoSMed42313_38-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Adar, Sara D.; Lianne Sheppard, Sverre Vedal, Joseph F. Polak, Paul D. Sampson, Ana V. Diez Roux, Matthew Budoff, David R. Jacobs Jr, R. Graham Barr, Karol Watson, Joel D. Kaufman (April 23, 2013). <a rel="nofollow" class="external text" href="http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001430">"Fine Particulate Air Pollution and the Progression of Carotid Intima-Medial Thickness: A Prospective Cohort Study from the Multi-Ethnic Study of Atherosclerosis and Air Pollution"</a>. <i>PLoS Medicine</i> <b>10</b> (4): e1001430. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1371%2Fjournal.pmed.1001430">10.1371/journal.pmed.1001430</a><span class="reference-accessdate">. Retrieved May 4, 2013</span>. "This early analysis from MESA suggests that higher long-term PM2.5 concentrations are associated with increased IMT progression and that greater reductions in PM2.5 are related to slower IMT progression."</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Fine+Particulate+Air+Pollution+and+the+Progression+of+Carotid+Intima-Medial+Thickness%3A+A+Prospective+Cohort+Study+from+the+Multi-Ethnic+Study+of+Atherosclerosis+and+Air+Pollution&amp;rft.au=Adar%2C+Sara+D.&amp;rft.aufirst=Sara+D.&amp;rft.aulast=Adar&amp;rft.date=April+23%2C+2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.plosmedicine.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pmed.1001430&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pmed.1001430&amp;rft.issue=4&amp;rft.jtitle=PLoS+Medicine&amp;rft.pages=e1001430&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-titleFood_Pyramids:_Nutrition_Source.2C_Harvard_School_of_Public_Health-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-titleFood_Pyramids:_Nutrition_Source.2C_Harvard_School_of_Public_Health_39-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.hsph.harvard.edu/nutritionsource/pyramids.html">"Food Pyramids: Nutrition Source, Harvard School of Public Health"</a>. <a rel="nofollow" class="external text" href="http://web.archive.org/web/20071226085222/http://www.hsph.harvard.edu/nutritionsource/pyramids.html">Archived</a> from the original on 26 December 2007<span class="reference-accessdate">. Retrieved 2007-11-25</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.btitle=Food+Pyramids%3A+Nutrition+Source%2C+Harvard+School+of+Public+Health&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.hsph.harvard.edu%2Fnutritionsource%2Fpyramids.html&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Taubes-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-Taubes_40-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Taubes G (March 2001). <a rel="nofollow" class="external text" href="http://www.sciencemag.org/cgi/pmidlookup?view=long&amp;pmid=11286266">"Nutrition. The soft science of dietary fat"</a>. <i>Science</i> <b>291</b> (5513): 2536–45. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1126%2Fscience.291.5513.2536">10.1126/science.291.5513.2536</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11286266">11286266</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Nutrition.+The+soft+science+of+dietary+fat&amp;rft.aulast=Taubes+G&amp;rft.au=Taubes+G&amp;rft.date=March+2001&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.sciencemag.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D11286266&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.291.5513.2536&amp;rft_id=info%3Apmid%2F11286266&amp;rft.issue=5513&amp;rft.jtitle=Science&amp;rft.pages=2536%E2%80%9345&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=291" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-SongJH-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-SongJH_41-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Song JH, Fujimoto K, Miyazawa T (2000). "Polyunsaturated (n-3) fatty acids susceptible to peroxidation are increased in plasma and tissue lipids of rats fed docosahexaenoic acid-containing oils". <i>J. Nutr.</i> <b>130</b> (12): 3028–33. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11110863">11110863</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Polyunsaturated+%28n-3%29+fatty+acids+susceptible+to+peroxidation+are+increased+in+plasma+and+tissue+lipids+of+rats+fed+docosahexaenoic+acid-containing+oils&amp;rft.aulast=Song+JH%2C+Fujimoto+K%2C+Miyazawa+T&amp;rft.au=Song+JH%2C+Fujimoto+K%2C+Miyazawa+T&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F11110863&amp;rft.issue=12&amp;rft.jtitle=J.+Nutr.&amp;rft.pages=3028%E2%80%9333&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=130" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-YapSC-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-YapSC_42-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Yap SC, Choo YM, Hew NF, <i>et al.</i> (1995). "Oxidative susceptibility of low density lipoprotein from rabbits fed atherogenic diets containing coconut, palm, or soybean oils". <i>Lipids</i> <b>30</b> (12): 1145–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2FBF02536616">10.1007/BF02536616</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8614305">8614305</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Oxidative+susceptibility+of+low+density+lipoprotein+from+rabbits+fed+atherogenic+diets+containing+coconut%2C+palm%2C+or+soybean+oils&amp;rft.aulast=Yap+SC%2C+Choo+YM%2C+Hew+NF%2C+%27%27et+al.%27%27&amp;rft.au=Yap+SC%2C+Choo+YM%2C+Hew+NF%2C+%27%27et+al.%27%27&amp;rft.date=1995&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2FBF02536616&amp;rft_id=info%3Apmid%2F8614305&amp;rft.issue=12&amp;rft.jtitle=Lipids&amp;rft.pages=1145%E2%80%9350&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Greco-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-Greco_43-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Greco AV, Mingrone G (1990). "Serum and biliary lipid pattern in rabbits feeding a diet enriched with unsaturated fatty acids". <i>Exp Pathol</i> <b>40</b> (1): 19–33. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0232-1513%2811%2980281-1">10.1016/S0232-1513(11)80281-1</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2279534">2279534</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Serum+and+biliary+lipid+pattern+in+rabbits+feeding+a+diet+enriched+with+unsaturated+fatty+acids&amp;rft.au=Greco+AV%2C+Mingrone+G&amp;rft.aulast=Greco+AV%2C+Mingrone+G&amp;rft.date=1990&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0232-1513%2811%2980281-1&amp;rft_id=info%3Apmid%2F2279534&amp;rft.issue=1&amp;rft.jtitle=Exp+Pathol&amp;rft.pages=19%E2%80%9333&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=40" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://medicalxpress.com/news/2013-08-scientist-orthodoxy-heart-disease.html">http://medicalxpress.com/news/2013-08-scientist-orthodoxy-heart-disease.html</a></span></li>
<li id="cite_note-pmid16249011-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16249011_45-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Mattes RD (2005). <a rel="nofollow" class="external text" href="http://linkinghub.elsevier.com/retrieve/pii/S0031-9384(05)00397-5">"Fat taste and lipid metabolism in humans"</a>. <i>Physiol. Behav.</i> <b>86</b> (5): 691–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.physbeh.2005.08.058">10.1016/j.physbeh.2005.08.058</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16249011">16249011</a>. "The rancid odor of an oxidized fat is readily detectable"</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Fat+taste+and+lipid+metabolism+in+humans&amp;rft.aulast=Mattes+RD&amp;rft.au=Mattes+RD&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0031-9384%2805%2900397-5&amp;rft_id=info%3Adoi%2F10.1016%2Fj.physbeh.2005.08.058&amp;rft_id=info%3Apmid%2F16249011&amp;rft.issue=5&amp;rft.jtitle=Physiol.+Behav.&amp;rft.pages=691%E2%80%937&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=86" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid12589185-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12589185_46-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Dobarganes C, Márquez-Ruiz G (2003). "Oxidized fats in foods". <i>Current Opinion in Clinical Nutrition and Metabolic Care</i> <b>6</b> (2): 157–63. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1097%2F00075197-200303000-00004">10.1097/00075197-200303000-00004</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12589185">12589185</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Oxidized+fats+in+foods&amp;rft.au=Dobarganes+C%2C+M%C3%A1rquez-Ruiz+G&amp;rft.aulast=Dobarganes+C%2C+M%C3%A1rquez-Ruiz+G&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F00075197-200303000-00004&amp;rft_id=info%3Apmid%2F12589185&amp;rft.issue=2&amp;rft.jtitle=Current+Opinion+in+Clinical+Nutrition+and+Metabolic+Care&amp;rft.pages=157%E2%80%9363&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text"><span class="citation web">supplements, FDA. <a rel="nofollow" class="external text" href="http://www.fda.gov/Food/DietarySupplements/default.htm">"Dietary Supplements"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.aufirst=FDA&amp;rft.aulast=supplements&amp;rft.au=supplements%2C+FDA&amp;rft.btitle=Dietary+Supplements&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FFood%2FDietarySupplements%2Fdefault.htm&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external free" href="http://circ.ahajournals.org/content/105/15/1804.short">http://circ.ahajournals.org/content/105/15/1804.short</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fcirc.ahajournals.org%2Fcontent%2F105%2F15%2F1804.short&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="font-size:100%" class="error citation-comment">Missing or empty <code>|title=</code> (<a href="/wiki/Help:CS1_errors#citation_missing_title" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><span class="citation journal">Schwartz, CJ; Valente AJ; Sprague EA; Kelley JL; Cayatte AJ; Mowery J. (Dec 1992). "Atherosclerosis. Potential targets for stabilization and regression". <i>Circulation</i> <b>86</b> (6 Suppl): III117–123. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1424045">1424045</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Atherosclerosis.+Potential+targets+for+stabilization+and+regression&amp;rft.au=Cayatte+AJ&amp;rft.aufirst=CJ&amp;rft.au=Kelley+JL&amp;rft.aulast=Schwartz&amp;rft.au=Mowery+J.&amp;rft.au=Schwartz%2C+CJ&amp;rft.au=Sprague+EA&amp;rft.au=Valente+AJ&amp;rft.date=Dec+1992&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F1424045&amp;rft.issue=6+Suppl&amp;rft.jtitle=Circulation&amp;rft.pages=III117%E2%80%93123&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=86" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Glagov-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-Glagov_50-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ (May 1987). "Compensatory enlargement of human atherosclerotic coronary arteries". <i>N. Engl. J. Med.</i> <b>316</b> (22): 1371–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1056%2FNEJM198705283162204">10.1056/NEJM198705283162204</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3574413">3574413</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Compensatory+enlargement+of+human+atherosclerotic+coronary+arteries&amp;rft.au=Glagov+S%2C+Weisenberg+E%2C+Zarins+CK%2C+Stankunavicius+R%2C+Kolettis+GJ&amp;rft.aulast=Glagov+S%2C+Weisenberg+E%2C+Zarins+CK%2C+Stankunavicius+R%2C+Kolettis+GJ&amp;rft.date=May+1987&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM198705283162204&amp;rft_id=info%3Apmid%2F3574413&amp;rft.issue=22&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1371%E2%80%935&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=316" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.pathologyatlas.ro/coronary-atherosclerosis-fibrous-plaque.php">"Coronary atherosclerosis — the fibrous plaque with calcification"</a>. www.pathologyatlas.ro<span class="reference-accessdate">. Retrieved 2010-03-25</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.btitle=Coronary+atherosclerosis+%E2%80%94+the+fibrous+plaque+with+calcification&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.pathologyatlas.ro%2Fcoronary-atherosclerosis-fibrous-plaque.php&amp;rft.pub=www.pathologyatlas.ro&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-MaseriFuster-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-MaseriFuster_52-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Maseri A, Fuster V (2003). "Is there a vulnerable plaque?". <i>Circulation</i> <b>107</b> (16): 2068–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1161%2F01.CIR.0000070585.48035.D1">10.1161/01.CIR.0000070585.48035.D1</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12719286">12719286</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Is+there+a+vulnerable+plaque%3F&amp;rft.aulast=Maseri+A%2C+Fuster+V&amp;rft.au=Maseri+A%2C+Fuster+V&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1161%2F01.CIR.0000070585.48035.D1&amp;rft_id=info%3Apmid%2F12719286&amp;rft.issue=16&amp;rft.jtitle=Circulation&amp;rft.pages=2068%E2%80%9371&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=107" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-53">^</a></b></span> <span class="reference-text"><span class="citation journal">T. E. Strandberg, S. Lehto, K. Pyörälä, A. Kesäniemi, H. Oksa (1997-01-11). <a rel="nofollow" class="external text" href="http://eurheartj.oxfordjournals.org/cgi/content/abstract/18/11/1725">"Cholesterol lowering after participation in the Scandinavian Simvastatin Survival Study (4S) in Finland"</a>. <i>European Heart Journal</i> <b>18</b> (11): 1725–7;. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1093%2Foxfordjournals.eurheartj.a015166">10.1093/oxfordjournals.eurheartj.a015166</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9402446">9402446</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Cholesterol+lowering+after+participation+in+the+Scandinavian+Simvastatin+Survival+Study+%284S%29+in+Finland&amp;rft.aulast=T.+E.+Strandberg%2C+S.+Lehto%2C+K.+Py%C3%B6r%C3%A4l%C3%A4%2C+A.+Kes%C3%A4niemi%2C+H.+Oksa&amp;rft.au=T.+E.+Strandberg%2C+S.+Lehto%2C+K.+Py%C3%B6r%C3%A4l%C3%A4%2C+A.+Kes%C3%A4niemi%2C+H.+Oksa&amp;rft.date=1997-01-11&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Feurheartj.oxfordjournals.org%2Fcgi%2Fcontent%2Fabstract%2F18%2F11%2F1725&amp;rft_id=info%3Adoi%2F10.1093%2Foxfordjournals.eurheartj.a015166&amp;rft_id=info%3Apmid%2F9402446&amp;rft.issue=11&amp;rft.jtitle=European+Heart+Journal&amp;rft.pages=1725%E2%80%937%3B&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=18" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-ASTEROID-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-ASTEROID_54-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Nissen SE, Nicholls SJ, Sipahi I, <i>et al.</i> (2006). <a rel="nofollow" class="external text" href="http://jama.ama-assn.org/cgi/reprint/jama;295/13/1556.pdf?ijkey=Md42dlk7z9TzyL8&amp;keytype=finite">"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial"</a> (PDF). <i>JAMA</i> <b>295</b> (13): 1556–65. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1001%2Fjama.295.13.jpc60002">10.1001/jama.295.13.jpc60002</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16533939">16533939</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Effect+of+very+high-intensity+statin+therapy+on+regression+of+coronary+atherosclerosis%3A+the+ASTEROID+trial&amp;rft.aulast=Nissen+SE%2C+Nicholls+SJ%2C+Sipahi+I%2C+%27%27et+al.%27%27&amp;rft.au=Nissen+SE%2C+Nicholls+SJ%2C+Sipahi+I%2C+%27%27et+al.%27%27&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjama.ama-assn.org%2Fcgi%2Freprint%2Fjama%3B295%2F13%2F1556.pdf%3Fijkey%3DMd42dlk7z9TzyL8%26keytype%3Dfinite&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.295.13.jpc60002&amp;rft_id=info%3Apmid%2F16533939&amp;rft.issue=13&amp;rft.jtitle=JAMA&amp;rft.pages=1556%E2%80%9365&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=295" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-CAPS-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-CAPS_55-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Downs JR, Clearfield M, Weis S, <i>et al.</i> (May 1998). <a rel="nofollow" class="external text" href="http://jama.ama-assn.org/cgi/pmidlookup?view=long&amp;pmid=9613910">"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study"</a>. <i>JAMA: the Journal of the American Medical Association</i> <b>279</b> (20): 1615–22. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1001%2Fjama.279.20.1615">10.1001/jama.279.20.1615</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9613910">9613910</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Primary+prevention+of+acute+coronary+events+with+lovastatin+in+men+and+women+with+average+cholesterol+levels%3A+results+of+AFCAPS%2FTexCAPS.+Air+Force%2FTexas+Coronary+Atherosclerosis+Prevention+Study&amp;rft.au=Downs+JR%2C+Clearfield+M%2C+Weis+S%2C+%27%27et+al.%27%27&amp;rft.aulast=Downs+JR%2C+Clearfield+M%2C+Weis+S%2C+%27%27et+al.%27%27&amp;rft.date=May+1998&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjama.ama-assn.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D9613910&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.279.20.1615&amp;rft_id=info%3Apmid%2F9613910&amp;rft.issue=20&amp;rft.jtitle=JAMA%3A+the+Journal+of+the+American+Medical+Association&amp;rft.pages=1615%E2%80%9322&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=279" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid1985608-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid1985608_56-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Bradford RH, Shear CL, Chremos AN, <i>et al.</i> (1991). "Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia". <i>Arch. Intern. Med.</i> <b>151</b> (1): 43–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1001%2Farchinte.151.1.43">10.1001/archinte.151.1.43</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1985608">1985608</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Expanded+Clinical+Evaluation+of+Lovastatin+%28EXCEL%29+study+results.+I.+Efficacy+in+modifying+plasma+lipoproteins+and+adverse+event+profile+in+8245+patients+with+moderate+hypercholesterolemia&amp;rft.au=Bradford+RH%2C+Shear+CL%2C+Chremos+AN%2C+%27%27et+al.%27%27&amp;rft.aulast=Bradford+RH%2C+Shear+CL%2C+Chremos+AN%2C+%27%27et+al.%27%27&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Farchinte.151.1.43&amp;rft_id=info%3Apmid%2F1985608&amp;rft.issue=1&amp;rft.jtitle=Arch.+Intern.+Med.&amp;rft.pages=43%E2%80%939&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=151" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15855581-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15855581_57-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Sever PS, Poulter NR, Dahlöf B, <i>et al.</i> (2005). "Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial—lipid-lowering arm (ASCOT-LLA)". <i>Diabetes Care</i> <b>28</b> (5): 1151–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2337%2Fdiacare.28.5.1151">10.2337/diacare.28.5.1151</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15855581">15855581</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Reduction+in+cardiovascular+events+with+atorvastatin+in+2%2C532+patients+with+type+2+diabetes%3A+Anglo-Scandinavian+Cardiac+Outcomes+Trial%E2%80%94lipid-lowering+arm+%28ASCOT-LLA%29&amp;rft.aulast=Sever+PS%2C+Poulter+NR%2C+Dahl%C3%B6f+B%2C+%27%27et+al.%27%27&amp;rft.au=Sever+PS%2C+Poulter+NR%2C+Dahl%C3%B6f+B%2C+%27%27et+al.%27%27&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2337%2Fdiacare.28.5.1151&amp;rft_id=info%3Apmid%2F15855581&amp;rft.issue=5&amp;rft.jtitle=Diabetes+Care&amp;rft.pages=1151%E2%80%937&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=28" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-58">^</a></b></span> <span class="reference-text"><span class="citation web">Linda Brookes, MSc. <a rel="nofollow" class="external text" href="http://www.medscape.com/viewarticle/536377">"SPARCL: Stroke Prevention by Aggressive Reduction in Cholesterol Levels"</a>. <a href="/wiki/Medscape" title="Medscape">Medscape</a>. <a rel="nofollow" class="external text" href="http://web.archive.org/web/20071221071848/http://www.medscape.com/viewarticle/536377">Archived</a> from the original on 21 December 2007<span class="reference-accessdate">. Retrieved 2007-11-19</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.aulast=Linda+Brookes%2C+MSc&amp;rft.au=Linda+Brookes%2C+MSc&amp;rft.btitle=SPARCL%3A+Stroke+Prevention+by+Aggressive+Reduction+in+Cholesterol+Levels&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F536377&amp;rft.pub=Medscape&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><span class="citation journal">Amarenco P, Bogousslavsky J, Callahan AS, <i>et al.</i> (2003). <a rel="nofollow" class="external text" href="http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowAbstract&amp;ProduktNr=224153&amp;ArtikelNr=72562">"Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study"</a>. <i>Cerebrovascular diseases</i> <b>16</b> (4): 389–95. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1159%2F000072562">10.1159/000072562</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14584489">14584489</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Design+and+baseline+characteristics+of+the+stroke+prevention+by+aggressive+reduction+in+cholesterol+levels+%28SPARCL%29+study&amp;rft.au=Amarenco+P%2C+Bogousslavsky+J%2C+Callahan+AS%2C+%27%27et+al.%27%27&amp;rft.aulast=Amarenco+P%2C+Bogousslavsky+J%2C+Callahan+AS%2C+%27%27et+al.%27%27&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcontent.karger.com%2FProdukteDB%2Fprodukte.asp%3FAktion%3DShowAbstract%26ProduktNr%3D224153%26ArtikelNr%3D72562&amp;rft_id=info%3Adoi%2F10.1159%2F000072562&amp;rft_id=info%3Apmid%2F14584489&amp;rft.issue=4&amp;rft.jtitle=Cerebrovascular+diseases&amp;rft.pages=389%E2%80%9395&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Fonarow.2C_G_2003-60"><span class="mw-cite-backlink">^ <a href="#cite_ref-Fonarow.2C_G_2003_60-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Fonarow.2C_G_2003_60-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Fonarow, G. Aggressive treatment of atherosclerosis: The time is now. Cleve. Clin. J. Med. 70, 431-+ (2003)</span></li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text">Ambrose, J. A. &amp; Barua, R. R. The pathophysiology of cigarette smoking and cardiovascular disease. <i>J Am Coll Cardiol</i>. 43(10) 1731-1737.</span></li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text">Pigozzi, F. et al. Endothelial (dys)function: the target of physical exercise for prevention and treatment of cardiovascular disease. J. Sports Med. Phys. Fitness 51, 260-267 (2011)</span></li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text">Koh, K.K. et al. Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction. <i>Atherosclerosis</i>. 209, 307-313 (2010).</span></li>
<li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><span class="citation journal">Taylor, F; Huffman, MD; Macedo, AF; Moore, TH; Burke, M; Davey Smith, G; Ward, K; Ebrahim, S (2013 Jan 31). "Statins for the primary prevention of cardiovascular disease.". <i>The Cochrane database of systematic reviews</i> <b>1</b>: CD004816. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2F14651858.CD004816.pub5">10.1002/14651858.CD004816.pub5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23440795">23440795</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Statins+for+the+primary+prevention+of+cardiovascular+disease.&amp;rft.au=Burke%2C+M&amp;rft.au=Davey+Smith%2C+G&amp;rft.au=Ebrahim%2C+S&amp;rft.aufirst=F&amp;rft.au=Huffman%2C+MD&amp;rft.aulast=Taylor&amp;rft.au=Macedo%2C+AF&amp;rft.au=Moore%2C+TH&amp;rft.au=Taylor%2C+F&amp;rft.au=Ward%2C+K&amp;rft.date=2013+Jan+31&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD004816.pub5&amp;rft_id=info%3Apmid%2F23440795&amp;rft.jtitle=The+Cochrane+database+of+systematic+reviews&amp;rft.pages=CD004816&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Check date values in: <code>|date=</code> (<a href="/wiki/Help:CS1_errors#bad_date" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text"><span class="citation journal">Vos E, Rose CP (November 2005). <a rel="nofollow" class="external text" href="http://www.cmaj.ca/cgi/content/full/173/10/1207-a">"Questioning the benefits of statins"</a>. <i>CMAJ</i> <b>173</b> (10): 1207; author reply 1210. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1503%2Fcmaj.1050120">10.1503/cmaj.1050120</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1277053">1277053</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16275976">16275976</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Questioning+the+benefits+of+statins&amp;rft.aulast=Vos+E%2C+Rose+CP&amp;rft.au=Vos+E%2C+Rose+CP&amp;rft.date=November+2005&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cmaj.ca%2Fcgi%2Fcontent%2Ffull%2F173%2F10%2F1207-a&amp;rft_id=info%3Adoi%2F10.1503%2Fcmaj.1050120&amp;rft_id=info%3Apmc%2F1277053&amp;rft_id=info%3Apmid%2F16275976&amp;rft.issue=10&amp;rft.jtitle=CMAJ&amp;rft.pages=1207%3B+author+reply+1210&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=173" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text">Shanmugma, N., Román-Rego, A., Ong, P. &amp; Kaski, J.C. Atherosclerotic plaque regression fact or fiction? Cardiovasc. Drugs Ther.24, 311-317 (2010).</span></li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><span class="citation journal">Price PA, Faus SA, Williamson MK (February 2000). <a rel="nofollow" class="external text" href="http://atvb.ahajournals.org/cgi/pmidlookup?view=long&amp;pmid=10669626">"Warfarin-induced artery calcification is accelerated by growth and vitamin D"</a>. <i>Arteriosclerosis, thrombosis, and vascular biology</i> <b>20</b> (2): 317–27. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1161%2F01.ATV.20.2.317">10.1161/01.ATV.20.2.317</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10669626">10669626</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Warfarin-induced+artery+calcification+is+accelerated+by+growth+and+vitamin+D&amp;rft.aulast=Price+PA%2C+Faus+SA%2C+Williamson+MK&amp;rft.au=Price+PA%2C+Faus+SA%2C+Williamson+MK&amp;rft.date=February+2000&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fatvb.ahajournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D10669626&amp;rft_id=info%3Adoi%2F10.1161%2F01.ATV.20.2.317&amp;rft_id=info%3Apmid%2F10669626&amp;rft.issue=2&amp;rft.jtitle=Arteriosclerosis%2C+thrombosis%2C+and+vascular+biology&amp;rft.pages=317%E2%80%9327&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-68">^</a></b></span> <span class="reference-text"><span class="citation journal">Geleijnse JM, Vermeer C, Grobbee DE, <i>et al.</i> (November 2004). <a rel="nofollow" class="external text" href="http://jn.nutrition.org/cgi/content/full/134/11/3100">"Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study"</a>. <i>J Nutr.</i> <b>134</b> (11): 3100–5. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15514282">15514282</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Dietary+intake+of+menaquinone+is+associated+with+a+reduced+risk+of+coronary+heart+disease%3A+the+Rotterdam+Study&amp;rft.au=Geleijnse+JM%2C+Vermeer+C%2C+Grobbee+DE%2C+%27%27et+al.%27%27&amp;rft.aulast=Geleijnse+JM%2C+Vermeer+C%2C+Grobbee+DE%2C+%27%27et+al.%27%27&amp;rft.date=November+2004&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjn.nutrition.org%2Fcgi%2Fcontent%2Ffull%2F134%2F11%2F3100&amp;rft_id=info%3Apmid%2F15514282&amp;rft.issue=11&amp;rft.jtitle=J+Nutr.&amp;rft.pages=3100%E2%80%935&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=134" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://lpi.oregonstate.edu/infocenter/vitamins/vitaminK/">"Linus Pauling Institute at Oregon State University"</a>. lpi.oregonstate.edu. <a rel="nofollow" class="external text" href="http://web.archive.org/web/20100407093811/http://lpi.oregonstate.edu/infocenter/vitamins/vitaminK/">Archived</a> from the original on 7 April 2010<span class="reference-accessdate">. Retrieved 2010-03-25</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.btitle=Linus+Pauling+Institute+at+Oregon+State+University&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Flpi.oregonstate.edu%2Finfocenter%2Fvitamins%2FvitaminK%2F&amp;rft.pub=lpi.oregonstate.edu&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><span class="citation journal">Barter PJ, Caulfield M, Eriksson M, <i>et al.</i> (November 2007). <a rel="nofollow" class="external text" href="http://content.nejm.org/cgi/content/full/NEJMoa0706628">"Effects of torcetrapib in patients at high risk for coronary events"</a>. <i>N Engl J Med.</i> <b>357</b> (21): 2109–22. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1056%2FNEJMoa0706628">10.1056/NEJMoa0706628</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17984165">17984165</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Effects+of+torcetrapib+in+patients+at+high+risk+for+coronary+events&amp;rft.au=Barter+PJ%2C+Caulfield+M%2C+Eriksson+M%2C+%27%27et+al.%27%27&amp;rft.aulast=Barter+PJ%2C+Caulfield+M%2C+Eriksson+M%2C+%27%27et+al.%27%27&amp;rft.date=November+2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Ffull%2FNEJMoa0706628&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa0706628&amp;rft_id=info%3Apmid%2F17984165&amp;rft.issue=21&amp;rft.jtitle=N+Engl+J+Med.&amp;rft.pages=2109%E2%80%9322&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=357" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Nilsson-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-Nilsson_71-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Jan Nilsson; <a href="/wiki/G%C3%B6ran_K._Hansson" title="Göran K. Hansson">Göran K. Hansson</a>; Prediman K. Shah (2005). <a rel="nofollow" class="external text" href="http://atvb.ahajournals.org/cgi/content/abstract/atvbaha;25/1/18">"Immunomodulation of Atherosclerosis – Implications for Vaccine Development—ATVB In Focus"</a>. <i>Arteriosclerosis, Thrombosis, and Vascular Biology</i> <b>5</b> (1): 18–28. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1161%2F01.ATV.0000149142.42590.a2">10.1161/01.ATV.0000149142.42590.a2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15514204">15514204</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Immunomodulation+of+Atherosclerosis+%E2%80%93+Implications+for+Vaccine+Development%E2%80%94ATVB+In+Focus&amp;rft.au=Jan+Nilsson%3B+G%C3%B6ran+K.+Hansson%3B+Prediman+K.+Shah&amp;rft.aulast=Jan+Nilsson%3B+G%C3%B6ran+K.+Hansson%3B+Prediman+K.+Shah&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fatvb.ahajournals.org%2Fcgi%2Fcontent%2Fabstract%2Fatvbaha%3B25%2F1%2F18&amp;rft_id=info%3Adoi%2F10.1161%2F01.ATV.0000149142.42590.a2&amp;rft_id=info%3Apmid%2F15514204&amp;rft.issue=1&amp;rft.jtitle=Arteriosclerosis%2C+Thrombosis%2C+and+Vascular+Biology&amp;rft.pages=18%E2%80%9328&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text"><span class="citation web">M Stitzinger (2007). <a rel="nofollow" class="external text" href="https://openaccess.leidenuniv.nl/dspace/bitstream/1887/9729/11/01.pdf">"Lipids, inflammation and atherosclerosis"</a> (pdf). The digital repository of Leiden University. <a rel="nofollow" class="external text" href="http://web.archive.org/web/20071127142751/https://openaccess.leidenuniv.nl/dspace/bitstream/1887/9729/11/01.pdf">Archived</a> from the original on 27 November 2007<span class="reference-accessdate">. Retrieved 2007-11-02</span>. "Results of clinical trials investigating anti-chlamydial antibiotics as an addition to standard therapy in patients with coronary artery disease have been inconsistent. Therefore, Andraws et al. conducted a meta- analysis of these clinical trials and found that evidence available to date does not demonstrate an overall benefit of antibiotic therapy in reducing mortality or cardiovascular events in patients with coronary artery disease."</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.aulast=M+Stitzinger&amp;rft.au=M+Stitzinger&amp;rft.btitle=Lipids%2C+inflammation+and+atherosclerosis&amp;rft.date=2007&amp;rft.genre=book&amp;rft_id=https%3A%2F%2Fopenaccess.leidenuniv.nl%2Fdspace%2Fbitstream%2F1887%2F9729%2F11%2F01.pdf&amp;rft.pub=The+digital+repository+of+Leiden+University&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-ReferenceA-73"><span class="mw-cite-backlink">^ <a href="#cite_ref-ReferenceA_73-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ReferenceA_73-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Chen WJ, Yin K, Zhao GJ, et al. The magic and mystery of microRNA-27 in atherosclerosis. <i>Atherosclerosis</i> 2012;222:314e23.</span></li>
<li id="cite_note-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-74">^</a></b></span> <span class="reference-text">Sacco J, Adeli K. MicroRNAs: emerging roles in lipid and lipoprotein metabolism. Curr Opin Lipidol 2012;23:220e5.</span></li>
<li id="cite_note-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-75">^</a></b></span> <span class="reference-text">Bommer GT, MacDougald OA. Regulation of lipid homeostasis by the bifunctional SREBF2-miR33a locus. <i>Cell Metab</i> 2011;13:241e7.</span></li>
<li id="cite_note-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-76">^</a></b></span> <span class="reference-text">Rayner KJ, Sheedy FJ, Esau CC, et al. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. <i>J Clin Invest</i> 2011;121:2921e31.</span></li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text">Rayner KJ, Esau CC, Hussain FN, et al. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. <i>Nature</i> 2011;478:404e7.</span></li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text">Iwakiri Y. A role of miR-33 for cell cycle progression and cell proliferation. Cell Cycle 2012;11:1057e8.</span></li>
<li id="cite_note-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-79">^</a></b></span> <span class="reference-text">Singaraja RR, Stahmer B, Brundert M, et al. Hepatic ATP-binding cassette transporter A1 is a key molecule in high-density lipoprotein cholesteryl ester metabolism in mice. Arterioscler Thromb Vasc Biol 2006;26:1821e7.</span></li>
<li id="cite_note-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-80">^</a></b></span> <span class="reference-text"><span class="citation web">Pfuntner A, Wier LM, Steiner C. (December 2013). <a rel="nofollow" class="external text" href="http://hcup-us.ahrq.gov/reports/statbriefs/sb168-Hospital-Costs-United-States-2011.jsp">"Costs for Hospital Stays in the United States, 2011."</a>. <i>HCUP Statistical Brief #168</i>. Rockville, MD: Agency for Healthcare Research and Quality.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtherosclerosis&amp;rft.atitle=Costs+for+Hospital+Stays+in+the+United+States%2C+2011.&amp;rft.aulast=Pfuntner+A%2C+Wier+LM%2C+Steiner+C.&amp;rft.au=Pfuntner+A%2C+Wier+LM%2C+Steiner+C.&amp;rft.date=December+2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fhcup-us.ahrq.gov%2Freports%2Fstatbriefs%2Fsb168-Hospital-Costs-United-States-2011.jsp&amp;rft.jtitle=HCUP+Statistical+Brief+%23168&amp;rft.place=Rockville%2C+MD&amp;rft.pub=Agency+for+Healthcare+Research+and+Quality&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit&amp;section=26" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table class="metadata mbox-small plainlinks" style="border:1px solid #aaa; background-color:#f9f9f9;">
<tr>
<td class="mbox-image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png" width="30" height="40" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x" /></td>
<td class="mbox-text plainlist" style="">Wikimedia Commons has media related to <i><b><a href="//commons.wikimedia.org/wiki/Category:Atherosclerosis" class="extiw" title="commons:Category:Atherosclerosis">Atherosclerosis</a></b></i>.</td>
</tr>
</table>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.dmoz.org/Health/Conditions_and_Diseases/Cardiovascular_Disorders/Vascular_Disorders/Atherosclerosis/">Atherosclerosis</a> on the <a href="/wiki/Open_Directory_Project" title="Open Directory Project">Open Directory Project</a></li>
<li>An open access review entitled <a rel="nofollow" class="external text" href="http://www.pharmamirror.com/pharmaceutical-articles/review-article-hypertension-and-pathogenesis-of-atherosclerosis/">Hypertension and the Pathogenesis of Atherosclerosis</a> on Pharma Mirror Magazine.</li>
<li>A four-minute animation of the atherosclerosis process, entitled "Pathogenesis of Acute MI," commissioned by Paul M. Ridker, MD, MPH, FACC, FAHA, at the Harvard Medical School, can be viewed at <a rel="nofollow" class="external text" href="http://www.pri-med.com/pmo/Home.aspx">pri-med.com</a>.</li>
</ul>
<table cellspacing="0" class="navbox" style="border-spacing:0;">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks hlist collapsible collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style="background:Silver;">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Vascular_diseases" title="Template:Vascular diseases"><span title="View this template" style=";background:Silver;background:none transparent;border:none;;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Vascular_diseases" title="Template talk:Vascular diseases"><span title="Discuss this template" style=";background:Silver;background:none transparent;border:none;;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Vascular_diseases&amp;action=edit"><span title="Edit this template" style=";background:Silver;background:none transparent;border:none;;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%;">
<ul>
<li><a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">Cardiovascular disease</a>: <a href="/wiki/Vascular_disease" title="Vascular disease">vascular disease</a></li>
<li><a href="/wiki/Circulatory_system" title="Circulatory system">Circulatory system</a> <a href="/wiki/Pathology" title="Pathology">pathology</a>
<ul>
<li><a href="/wiki/ICD-10_Chapter_IX:_Diseases_of_the_circulatory_system#.28I70.E2.80.93I79.29_Diseases_of_arteries.2C_arterioles_and_capillaries" title="ICD-10 Chapter IX: Diseases of the circulatory system">I70–I99</a>, <a href="/wiki/List_of_ICD-9_codes_390%E2%80%93459:_diseases_of_the_circulatory_system#Diseases_of_arteries.2C_arterioles.2C_and_capillaries_.28440.E2.80.93448.29" title="List of ICD-9 codes 390–459: diseases of the circulatory system">440–456</a></li>
</ul>
</li>
</ul>
</div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:MistyRose;;"><a href="/wiki/Arteries" title="Arteries" class="mw-redirect">Arteries</a>, <a href="/wiki/Arteriole" title="Arteriole">arterioles</a><br />
and <a href="/wiki/Capillaries" title="Capillaries" class="mw-redirect">capillaries</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Inflammation" title="Inflammation">Inflammation</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Arteritis" title="Arteritis">Arteritis</a>
<ul>
<li><a href="/wiki/Aortitis" title="Aortitis">Aortitis</a></li>
</ul>
</li>
<li><a href="/wiki/Thromboangiitis_obliterans" title="Thromboangiitis obliterans">Buerger's disease</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Peripheral_vascular_disease" title="Peripheral vascular disease">Arterial occlusive disease</a> /<br />
<a href="/wiki/Peripheral_vascular_disease" title="Peripheral vascular disease">peripheral vascular disease</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Arteriosclerosis" title="Arteriosclerosis">Arteriosclerosis</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><span class="wrap"><strong class="selflink">Atherosclerosis</strong></span>
<ul>
<li><span class="wrap"><a href="/wiki/Foam_cell" title="Foam cell">Foam cell</a></span></li>
<li><span class="wrap"><a href="/wiki/Fatty_streak" title="Fatty streak">Fatty streak</a></span></li>
<li><span class="wrap"><a href="/wiki/Atheroma" title="Atheroma">Atheroma</a></span></li>
<li><span class="wrap"><a href="/wiki/Intermittent_claudication" title="Intermittent claudication">Intermittent claudication</a></span></li>
</ul>
</li>
<li><a href="/wiki/Monckeberg%27s_arteriosclerosis" title="Monckeberg's arteriosclerosis">Monckeberg's arteriosclerosis</a></li>
<li><span class="wrap"><a href="/wiki/Arteriolosclerosis" title="Arteriolosclerosis">Arteriolosclerosis</a></span>
<ul>
<li><span class="wrap"><a href="/wiki/Hyaline_arteriolosclerosis" title="Hyaline arteriolosclerosis">Hyaline</a></span></li>
<li><span class="wrap"><a href="/wiki/Hyperplastic_arteriolosclerosis" title="Hyperplastic arteriolosclerosis">Hyperplastic</a></span></li>
<li><span class="wrap"><a href="/wiki/Cholesterol" title="Cholesterol">Cholesterol</a></span></li>
<li><span class="wrap"><a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">LDL</a></span></li>
<li><span class="wrap"><a href="/wiki/Oxycholesterol" title="Oxycholesterol">Oxycholesterol</a></span></li>
<li><span class="wrap"><a href="/wiki/Trans_fat" title="Trans fat">Trans fat</a></span></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Stenosis" title="Stenosis">Stenosis</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Carotid_artery_stenosis" title="Carotid artery stenosis">Carotid artery stenosis</a></li>
<li><a href="/wiki/Renal_artery_stenosis" title="Renal artery stenosis">Renal artery stenosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">Other</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Aortoiliac_occlusive_disease" title="Aortoiliac occlusive disease">Aortoiliac occlusive disease</a></li>
<li><a href="/wiki/Degos_disease" title="Degos disease">Degos disease</a></li>
<li><a href="/wiki/Erythromelalgia" title="Erythromelalgia">Erythromelalgia</a></li>
<li><a href="/wiki/Fibromuscular_dysplasia" title="Fibromuscular dysplasia">Fibromuscular dysplasia</a></li>
<li><a href="/wiki/Raynaud%27s_phenomenon" title="Raynaud's phenomenon">Raynaud's phenomenon</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Aneurysm" title="Aneurysm">Aneurysm</a> / <a href="/wiki/Dissection_(medical)" title="Dissection (medical)">dissection</a> /<br />
<a href="/wiki/Pseudoaneurysm" title="Pseudoaneurysm">pseudoaneurysm</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i>torso</i>: <a href="/wiki/Aortic_aneurysm" title="Aortic aneurysm">Aortic aneurysm</a>
<ul>
<li><a href="/wiki/Abdominal_aortic_aneurysm" title="Abdominal aortic aneurysm">Abdominal aortic aneurysm</a></li>
<li><a href="/wiki/Thoracic_aortic_aneurysm" title="Thoracic aortic aneurysm">Thoracic aortic aneurysm</a></li>
</ul>
</li>
<li><a href="/wiki/Aortic_dissection" title="Aortic dissection">Aortic dissection</a></li>
<li><a href="/wiki/Coronary_artery_aneurysm" title="Coronary artery aneurysm">Coronary artery aneurysm</a></li>
<li><i>head / neck</i>
<ul>
<li><a href="/wiki/Intracranial_aneurysm" title="Intracranial aneurysm">Intracranial aneurysm</a></li>
<li><a href="/wiki/Intracranial_berry_aneurysm" title="Intracranial berry aneurysm" class="mw-redirect">Intracranial berry aneurysm</a></li>
<li><a href="/wiki/Carotid_artery_dissection" title="Carotid artery dissection">Carotid artery dissection</a></li>
<li><a href="/wiki/Vertebral_artery_dissection" title="Vertebral artery dissection">Vertebral artery dissection</a></li>
<li><a href="/wiki/Familial_aortic_dissection" title="Familial aortic dissection">Familial aortic dissection</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Vascular_malformation" title="Vascular malformation">Vascular malformation</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Arteriovenous_fistula" title="Arteriovenous fistula">Arteriovenous fistula</a></li>
<li><a href="/wiki/Arteriovenous_malformation" title="Arteriovenous malformation">Arteriovenous malformation</a></li>
<li><a href="/wiki/Telangiectasia" title="Telangiectasia">Telangiectasia</a>
<ul>
<li><a href="/wiki/Hereditary_hemorrhagic_telangiectasia" title="Hereditary hemorrhagic telangiectasia">Hereditary hemorrhagic telangiectasia</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Nevus#Vascular_nevus" title="Nevus">Vascular nevus</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Cherry_hemangioma" title="Cherry hemangioma">Cherry hemangioma</a></li>
<li><a href="/wiki/Halo_nevus" title="Halo nevus">Halo nevus</a></li>
<li><a href="/wiki/Spider_angioma" title="Spider angioma">Spider angioma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:MistyRose;;"><a href="/wiki/Vein" title="Vein">Veins</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Inflammation" title="Inflammation">Inflammation</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Phlebitis" title="Phlebitis">Phlebitis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Venous_thrombosis" title="Venous thrombosis">Venous thrombosis</a> /<br />
<a href="/wiki/Thrombophlebitis" title="Thrombophlebitis">Thrombophlebitis</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i>primarily lower limb</i>
<ul>
<li><a href="/wiki/Deep_vein_thrombosis" title="Deep vein thrombosis">Deep vein thrombosis</a></li>
</ul>
</li>
<li><i>abdomen</i>
<ul>
<li><a href="/wiki/Hepatic_veno-occlusive_disease" title="Hepatic veno-occlusive disease">Hepatic veno-occlusive disease</a></li>
<li><a href="/wiki/Budd%E2%80%93Chiari_syndrome" title="Budd–Chiari syndrome">Budd–Chiari syndrome</a></li>
<li><a href="/wiki/May%E2%80%93Thurner_syndrome" title="May–Thurner syndrome">May–Thurner syndrome</a></li>
<li><a href="/wiki/Portal_vein_thrombosis" title="Portal vein thrombosis">Portal vein thrombosis</a></li>
<li><a href="/wiki/Renal_vein_thrombosis" title="Renal vein thrombosis">Renal vein thrombosis</a></li>
</ul>
</li>
<li><i>upper limb / torso</i>
<ul>
<li><a href="/wiki/Mondor%27s_disease" title="Mondor's disease">Mondor's disease</a></li>
<li><a href="/wiki/Paget%E2%80%93Schroetter_disease" title="Paget–Schroetter disease">Paget–Schroetter disease</a></li>
</ul>
</li>
<li><i>head</i>
<ul>
<li><a href="/wiki/Cerebral_venous_sinus_thrombosis" title="Cerebral venous sinus thrombosis">Cerebral venous sinus thrombosis</a></li>
</ul>
</li>
<li><a href="/wiki/Post-thrombotic_syndrome" title="Post-thrombotic syndrome">Post-thrombotic syndrome</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Varicose_veins" title="Varicose veins">Varicose veins</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Gastric_varices" title="Gastric varices">Gastric varices</a></li>
<li><a href="/wiki/Portacaval_anastomosis" title="Portacaval anastomosis">Portacaval anastomosis</a>
<ul>
<li><a href="/wiki/Caput_medusae" title="Caput medusae">Caput medusae</a></li>
<li><a href="/wiki/Esophageal_varices" title="Esophageal varices">Esophageal varices</a></li>
<li><a href="/wiki/Hemorrhoid" title="Hemorrhoid">Hemorrhoid</a></li>
</ul>
</li>
<li><a href="/wiki/Varicocele" title="Varicocele">Varicocele</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">Other</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Chronic_venous_insufficiency" title="Chronic venous insufficiency">Chronic venous insufficiency</a></li>
<li><a href="/wiki/Chronic_cerebrospinal_venous_insufficiency" title="Chronic cerebrospinal venous insufficiency">Chronic cerebrospinal venous insufficiency</a></li>
<li><a href="/wiki/Superior_vena_cava_syndrome" title="Superior vena cava syndrome">Superior vena cava syndrome</a></li>
<li><a href="/wiki/Inferior_vena_cava_syndrome" title="Inferior vena cava syndrome">Inferior vena cava syndrome</a></li>
<li><a href="/wiki/Venous_ulcer" title="Venous ulcer">Venous ulcer</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:MistyRose;;">Arteries or veins</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Angiopathy" title="Angiopathy">Angiopathy</a>
<ul>
<li><a href="/wiki/Macroangiopathy" title="Macroangiopathy" class="mw-redirect">Macroangiopathy</a></li>
<li><a href="/wiki/Microangiopathy" title="Microangiopathy">Microangiopathy</a></li>
</ul>
</li>
<li><a href="/wiki/Embolism" title="Embolism">Embolism</a>
<ul>
<li><a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">Pulmonary embolism</a></li>
<li><a href="/wiki/Cholesterol_embolism" title="Cholesterol embolism">Cholesterol embolism</a></li>
<li><a href="/wiki/Paradoxical_embolism" title="Paradoxical embolism">Paradoxical embolism</a></li>
</ul>
</li>
<li><a href="/wiki/Thrombosis" title="Thrombosis">Thrombosis</a></li>
<li><a href="/wiki/Vasculitis" title="Vasculitis">Vasculitis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:MistyRose;;"><a href="/wiki/Blood_pressure" title="Blood pressure">Blood pressure</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Hypertension" title="Hypertension">Hypertension</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Hypertensive_heart_disease" title="Hypertensive heart disease">Hypertensive heart disease</a></li>
<li><a href="/wiki/Hypertensive_emergency" title="Hypertensive emergency">Hypertensive emergency</a></li>
<li><a href="/wiki/Hypertensive_nephropathy" title="Hypertensive nephropathy">Hypertensive nephropathy</a></li>
<li><a href="/wiki/Essential_hypertension" title="Essential hypertension">Essential hypertension</a></li>
<li><a href="/wiki/Secondary_hypertension" title="Secondary hypertension">Secondary hypertension</a>
<ul>
<li><a href="/wiki/Renovascular_hypertension" title="Renovascular hypertension">Renovascular hypertension</a></li>
</ul>
</li>
<li><a href="/wiki/Benign_hypertension" title="Benign hypertension">Benign hypertension</a></li>
<li><a href="/wiki/Pulmonary_hypertension" title="Pulmonary hypertension">Pulmonary hypertension</a></li>
<li><a href="/wiki/Systolic_hypertension" title="Systolic hypertension">Systolic hypertension</a></li>
<li><a href="/wiki/White_coat_hypertension" title="White coat hypertension">White coat hypertension</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Hypotension" title="Hypotension">Hypotension</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Orthostatic_hypotension" title="Orthostatic hypotension">Orthostatic hypotension</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;;">
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;background:transparent;color:inherit;;">
<div style="padding:0px;;">
<table cellspacing="0" class="navbox-columns-table" style="text-align:left;width:100%;">
<tr style="vertical-align:top;">
<td style="padding:0px;text-align:center;background:MistyRose;;;text-align:center;background:MistyRose;;width:10em;">
<div>
<p><a href="/wiki/Template:Medicine_navs" title="Template:Medicine navs">M</a>: <a href="/wiki/Circulatory_system" title="Circulatory system">VAS</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:MistyRose;;;text-align:center;background:white;;width:10em;">
<div>
<p><a href="/wiki/Template:Arteries_and_veins" title="Template:Arteries and veins">anat</a> (a:<a href="/wiki/Template:Arteries_of_head_and_neck" title="Template:Arteries of head and neck">h</a>/<a href="/wiki/Template:Arteries_of_upper_limbs" title="Template:Arteries of upper limbs">u</a>/<a href="/wiki/Template:Arteries_of_thorax" title="Template:Arteries of thorax">t</a>/<a href="/wiki/Template:Arteries_of_abdomen" title="Template:Arteries of abdomen">a</a>/<a href="/wiki/Template:Arteries_of_lower_limbs" title="Template:Arteries of lower limbs">l</a>,v:<a href="/wiki/Template:Veins_of_the_head_and_neck" title="Template:Veins of the head and neck">h</a>/<a href="/wiki/Template:Veins_of_the_upper_extremity" title="Template:Veins of the upper extremity">u</a>/<a href="/wiki/Template:Veins_of_the_thorax_and_vertebral_column" title="Template:Veins of the thorax and vertebral column">t</a>/<a href="/wiki/Template:Veins_of_the_abdomen_and_pelvis" title="Template:Veins of the abdomen and pelvis">a</a>/<a href="/wiki/Template:Veins_of_the_lower_extremity" title="Template:Veins of the lower extremity">l</a>)/<a href="/wiki/Template:Cardiovascular_physiology" title="Template:Cardiovascular physiology">phys</a>/<a href="/wiki/Template:Development_of_mammalian_circulatory_system" title="Template:Development of mammalian circulatory system">devp</a>/<a href="/wiki/Template:Human_cell_types_derived_primarily_from_mesoderm" title="Template:Human cell types derived primarily from mesoderm">cell</a>/<a href="/wiki/Template:Angiogenic_proteins" title="Template:Angiogenic proteins">prot</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:MistyRose;;;text-align:center;background:silver;;width:10em;">
<div>
<p><a href="/wiki/Template:Vascular_diseases" title="Template:Vascular diseases">noco</a>/<a href="/wiki/Template:Systemic_vasculitis" title="Template:Systemic vasculitis">syva</a>/<a href="/wiki/Template:Congenital_vascular_defects" title="Template:Congenital vascular defects">cong</a>/<a href="/wiki/Template:Lymphatic_vessel_disease" title="Template:Lymphatic vessel disease">lyvd</a>/<a href="/wiki/Template:Vascular_tumors" title="Template:Vascular tumors">tumr</a>, <a href="/wiki/Template:Cardiovascular_system_symptoms_and_signs" title="Template:Cardiovascular system symptoms and signs">sysi</a>/<a href="/wiki/Template:Eponymous_medical_signs_for_cardiovascular_system" title="Template:Eponymous medical signs for cardiovascular system">epon</a>, <a href="/wiki/Template:Chest_trauma" title="Template:Chest trauma">injr</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:MistyRose;;;text-align:center;background:#ccf;;width:10em;">
<div>
<p><a href="/wiki/Template:Vascular_procedures" title="Template:Vascular procedures">proc</a>, drug (<a href="/wiki/Template:Sympatholytic_antihypertensives" title="Template:Sympatholytic antihypertensives">C2s</a>+<a href="/wiki/Template:Nonsympatholytic_vasodilatory_antihypertensives" title="Template:Nonsympatholytic vasodilatory antihypertensives">n</a>/<a href="/wiki/Template:Diuretics" title="Template:Diuretics">3</a>/<a href="/wiki/Template:Peripheral_vasodilators" title="Template:Peripheral vasodilators">4</a>/<a href="/wiki/Template:Vasoprotectives" title="Template:Vasoprotectives">5</a>/<a href="/wiki/Template:Beta_blockers" title="Template:Beta blockers">7</a>/<a href="/wiki/Template:Channel_blockers" title="Template:Channel blockers">8</a>/<a href="/wiki/Template:Agents_acting_on_the_renin-angiotensin_system" title="Template:Agents acting on the renin-angiotensin system">9</a>)</p>
</div>
</td>
</tr>
</table>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1037
CPU time usage: 3.564 seconds
Real time usage: 3.701 seconds
Preprocessor visited node count: 6864/1000000
Preprocessor generated node count: 31118/1500000
Post‐expand include size: 232632/2048000 bytes
Template argument size: 11690/2048000 bytes
Highest expansion depth: 13/40
Expensive parser function count: 8/500
Lua time usage: 0.201/10.000 seconds
Lua memory usage: 3.77 MB/50 MB
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:85385-0!*!0!!en!4!* and timestamp 20140330020417
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>								<div class="printfooter">
				Retrieved from "<a href="http://en.wikipedia.org/w/index.php?title=Atherosclerosis&amp;oldid=601810521">http://en.wikipedia.org/w/index.php?title=Atherosclerosis&amp;oldid=601810521</a>"				</div>
												<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Diseases_of_arteries,_arterioles_and_capillaries" title="Category:Diseases of arteries, arterioles and capillaries">Diseases of arteries, arterioles and capillaries</a></li><li><a href="/wiki/Category:Vascular_diseases" title="Category:Vascular diseases">Vascular diseases</a></li><li><a href="/wiki/Category:Medical_conditions_related_to_obesity" title="Category:Medical conditions related to obesity">Medical conditions related to obesity</a></li><li><a href="/wiki/Category:Inflammations" title="Category:Inflammations">Inflammations</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Pages_containing_cite_templates_with_deprecated_parameters" title="Category:Pages containing cite templates with deprecated parameters">Pages containing cite templates with deprecated parameters</a></li><li><a href="/wiki/Category:Pages_with_citations_lacking_titles" title="Category:Pages with citations lacking titles">Pages with citations lacking titles</a></li><li><a href="/wiki/Category:Pages_with_citations_having_bare_URLs" title="Category:Pages with citations having bare URLs">Pages with citations having bare URLs</a></li><li><a href="/wiki/Category:CS1_errors:_dates" title="Category:CS1 errors: dates">CS1 errors: dates</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_March_2013" title="Category:Articles with unsourced statements from March 2013">Articles with unsourced statements from March 2013</a></li><li><a href="/wiki/Category:Articles_needing_additional_references_from_October_2013" title="Category:Articles needing additional references from October 2013">Articles needing additional references from October 2013</a></li><li><a href="/wiki/Category:All_articles_needing_additional_references" title="Category:All articles needing additional references">All articles needing additional references</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_August_2010" title="Category:Articles with unsourced statements from August 2010">Articles with unsourced statements from August 2010</a></li><li><a href="/wiki/Category:Wikipedia_articles_needing_clarification_from_December_2010" title="Category:Wikipedia articles needing clarification from December 2010">Wikipedia articles needing clarification from December 2010</a></li><li><a href="/wiki/Category:Articles_using_fixed_number_of_columns_in_reflist" title="Category:Articles using fixed number of columns in reflist">Articles using fixed number of columns in reflist</a></li><li><a href="/wiki/Category:Commons_category_with_local_link_same_as_on_Wikidata" title="Category:Commons category with local link same as on Wikidata">Commons category with local link same as on Wikidata</a></li><li><a href="/wiki/Category:Articles_with_Open_Directory_Project_links" title="Category:Articles with Open Directory Project links">Articles with Open Directory Project links</a></li></ul></div></div>												<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>
			<div id="mw-head">
				<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
	<h3 id="p-personal-label">Personal tools</h3>
	<ul>
<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Atherosclerosis&amp;type=signup">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Atherosclerosis" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>	</ul>
</div>
				<div id="left-navigation">
					<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
	<h3 id="p-namespaces-label">Namespaces</h3>
	<ul>
					<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Atherosclerosis"  title="View the content page [c]" accesskey="c">Article</a></span></li>
					<li  id="ca-talk"><span><a href="/wiki/Talk:Atherosclerosis"  title="Discussion about the content page [t]" accesskey="t">Talk</a></span></li>
			</ul>
</div>
<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
	<h3 id="mw-vector-current-variant">
		</h3>
	<h3 id="p-variants-label"><span>Variants</span><a href="#"></a></h3>
	<div class="menu">
		<ul>
					</ul>
	</div>
</div>
				</div>
				<div id="right-navigation">
					<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
	<h3 id="p-views-label">Views</h3>
	<ul>
					<li id="ca-view" class="selected"><span><a href="/wiki/Atherosclerosis" >Read</a></span></li>
					<li id="ca-edit"><span><a href="/w/index.php?title=Atherosclerosis&amp;action=edit"  title="You can edit this page. &#10;Please review your changes before saving. [e]" accesskey="e">Edit</a></span></li>
					<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Atherosclerosis&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
			</ul>
</div>
<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
	<h3 id="p-cactions-label"><span>Actions</span><a href="#"></a></h3>
	<div class="menu">
		<ul>
					</ul>
	</div>
</div>
<div id="p-search" role="search">
	<h3><label for="searchInput">Search</label></h3>
	<form action="/w/index.php" id="searchform">
					<div id="simpleSearch">
					<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />		</div>
	</form>
</div>
				</div>
			</div>
			<div id="mw-panel">
					<div id="p-logo" role="banner"><a style="background-image: url(//upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
				<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
	<h3 id='p-navigation-label'>Navigation</h3>
	<div class="body">
		<ul>
			<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
			<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
			<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li>
			<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
			<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			<li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li>
			<li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikimedia Shop</a></li>
		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
	<h3 id='p-interaction-label'>Interaction</h3>
	<div class="body">
		<ul>
			<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
			<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
			<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
			<li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>
		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
	<h3 id='p-tb-label'>Tools</h3>
	<div class="body">
		<ul>
			<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Atherosclerosis" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
			<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Atherosclerosis" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
			<li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li>
			<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li>
			<li id="t-permalink"><a href="/w/index.php?title=Atherosclerosis&amp;oldid=601810521" title="Permanent link to this revision of the page">Permanent link</a></li>
			<li id="t-info"><a href="/w/index.php?title=Atherosclerosis&amp;action=info">Page information</a></li>
			<li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q13380381" title="Link to connected data repository item [g]" accesskey="g">Data item</a></li>
<li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Atherosclerosis&amp;id=601810521" title="Information on how to cite this page">Cite this page</a></li>		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
	<h3 id='p-coll-print_export-label'>Print/export</h3>
	<div class="body">
		<ul>
			<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Atherosclerosis">Create a book</a></li>
			<li id="coll-download-as-rl"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Atherosclerosis&amp;oldid=601810521&amp;writer=rl">Download as PDF</a></li>
			<li id="t-print"><a href="/w/index.php?title=Atherosclerosis&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>
		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
	<h3 id='p-lang-label'>Languages</h3>
	<div class="body">
		<ul>
			<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D8%AA%D8%B5%D9%84%D8%A8_%D8%B9%D8%B5%D9%8A%D8%AF%D9%8A" title="تصلب عصيدي – Arabic" lang="ar" hreflang="ar">العربية</a></li>
			<li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/Aterosclerosi" title="Aterosclerosi – Catalan" lang="ca" hreflang="ca">Català</a></li>
			<li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Ateroesclerosis" title="Ateroesclerosis – Spanish" lang="es" hreflang="es">Español</a></li>
			<li class="interlanguage-link interwiki-ga"><a href="//ga.wikipedia.org/wiki/Ait%C3%A9iriscl%C3%A9ar%C3%B3is" title="Aitéiriscléaróis – Irish" lang="ga" hreflang="ga">Gaeilge</a></li>
			<li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Aterosclerosi" title="Aterosclerosi – Italian" lang="it" hreflang="it">Italiano</a></li>
			<li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%98%D7%A8%D7%A9%D7%AA_%D7%A2%D7%95%D7%A8%D7%A7%D7%99%D7%9D" title="טרשת עורקים – Hebrew" lang="he" hreflang="he">עברית</a></li>
			<li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Atheromatose" title="Atheromatose – Dutch" lang="nl" hreflang="nl">Nederlands</a></li>
			<li class="interlanguage-link interwiki-no"><a href="//no.wikipedia.org/wiki/%C3%85reforkalkning" title="Åreforkalkning – Norwegian (bokmål)" lang="no" hreflang="no">Norsk bokmål</a></li>
			<li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Mia%C5%BCd%C5%BCyca" title="Miażdżyca – Polish" lang="pl" hreflang="pl">Polski</a></li>
			<li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Aterosclerose" title="Aterosclerose – Portuguese" lang="pt" hreflang="pt">Português</a></li>
			<li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%90%D1%82%D0%B5%D1%80%D0%BE%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7" title="Атеросклероз – Russian" lang="ru" hreflang="ru">Русский</a></li>
			<li class="interlanguage-link interwiki-sk"><a href="//sk.wikipedia.org/wiki/Ateroskler%C3%B3za" title="Ateroskleróza – Slovak" lang="sk" hreflang="sk">Slovenčina</a></li>
			<li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Ateroskleroosi" title="Ateroskleroosi – Finnish" lang="fi" hreflang="fi">Suomi</a></li>
			<li class="interlanguage-link interwiki-ta"><a href="//ta.wikipedia.org/wiki/%E0%AE%A4%E0%AE%AE%E0%AE%A9%E0%AE%BF%E0%AE%95%E0%AF%8D%E0%AE%95%E0%AF%82%E0%AE%B4%E0%AF%8D%E0%AE%AE%E0%AF%88%E0%AE%A4%E0%AF%8D_%E0%AE%A4%E0%AE%9F%E0%AE%BF%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AF%81" title="தமனிக்கூழ்மைத் தடிப்பு – Tamil" lang="ta" hreflang="ta">தமிழ்</a></li>
			<li class="interlanguage-link interwiki-tr"><a href="//tr.wikipedia.org/wiki/Ateroskleroz" title="Ateroskleroz – Turkish" lang="tr" hreflang="tr">Türkçe</a></li>
			<li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E5%8A%A8%E8%84%89%E7%B2%A5%E6%A0%B7%E7%A1%AC%E5%8C%96" title="动脉粥样硬化 – Chinese" lang="zh" hreflang="zh">中文</a></li>
			<li class="uls-p-lang-dummy"><a href="#"></a></li>
			<li class="wbc-editpage"><a href="//www.wikidata.org/wiki/Q13380381#sitelinks-wikipedia" title="Edit interlanguage links">Edit links</a></li>
		</ul>
	</div>
</div>
			</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 29 March 2014 at 14:45.<br /></li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy.</a> <br/>
Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a class="external" href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/wiki/Atherosclerosis" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
					<li id="footer-copyrightico">
						<a href="//wikimediafoundation.org/"><img src="//bits.wikimedia.org/images/wikimedia-button.png" width="88" height="31" alt="Wikimedia Foundation"/></a>
					</li>
					<li id="footer-poweredbyico">
						<a href="//www.mediawiki.org/"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" width="88" height="31" /></a>
					</li>
				</ul>
						<div style="clear:both"></div>
		</div>
		<script>/*<![CDATA[*/window.jQuery && jQuery.ready();/*]]>*/</script><script>if(window.mw){
mw.loader.state({"site":"loading","user":"ready","user.groups":"ready"});
}</script>
<script>if(window.mw){
mw.loader.load(["ext.cite","mobile.desktop","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.DRN-wizard","ext.gadget.charinsert","mw.MwEmbedSupport.style","ext.navigationTiming","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage","skins.vector.collapsibleNav"],null,true);
}</script>
<script src="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=scripts&amp;skin=vector&amp;*"></script>
<!-- Served by mw1175 in 0.280 secs. -->
	</body>
</html>
